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Baculoviruses are insect specific 
viruses which can also transfer 
genes into mammalian cells. In 
this thesis, the receptor that the 
virus uses to bind to mammalian 
cells was discovered. Also, factors 
that influence the outcome of 
baculovirus transduction were 
identified. The results reveal 
important insights about cellular 
factors affecting baculovirus 
transduction and may be used in 
the future to develop improved 
viral vectors for gene transfer 
purposes.
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ABSTRACT 
 
Baculoviruses are insect specific viruses generally encountered in nature. In the recent 
decades they have been widely utilized for different purposes of biotechnology. The 
discovery of the viruses’ capabilities to transduce mammalian cells has led to their wide use 
for gene transfer purposes in mammalian cells. Though the virus is able to transduce 
several types of mammalian cells, still most of the details on the baculoviral uptake into the 
traditionally nontarget cells are unclear. Also, the receptor that the virus utilizes has not 
been identified so far. 
The purpose of this thesis was to examine in detail the interaction of baculovirus virions 
with the surface of mammalian cells and identify the exact member of the heparan sulfate 
proteoglycan family to which the virus binds. According to our results, the baculovirus 
binds specifically to N- and 6-O-sulfated syndecan-1 at the surface of mammalian cells. This 
is the first time that the viral receptor in mammalian cells has been identified.  
Since the outcome of baculovirus transduction in vitro is not only dependent on the cell 
type but also on the conditions of transduction, we also wanted to examine how the use of 
different kinds of cell culture media affect the transduction efficiency. Our results show that 
the use of optimized cell culture medium RPMI 1640 leads to improved nuclear entry of 
baculoviruses and the medium effect is related to intermediate filament vimentin 
rearrangement.  
Since some mammalian cells are more permissive to baculoviral transduction compared 
to others, we also wanted to investigate what the possible crucial differences between the 
cells and their phenotypes were. According to our data, the poorly permissive cells showed 
differences in the expression of F-actin, vimentin, PKCα and PKCε compared to permissive 
cells. The use of RPMI 1640 lead to lower expression levels of syntenin and differences in 
the regulation of PKCα and ε along with a looser vimentin network. When intracellular 
kinase activation was further studied in these permissive and poorly permissive 
phenotypes, differences in kinase regulation were detected.  
In conclusion, this thesis reveals important aspects which influence baculoviral uptake 
and trafficking in mammalian cells and identifies for the first time a receptor that the virus 
uses to bind to and enter into mammalian cells, syndecan-1.   
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TIIVISTELMÄ 
 
Bakulovirukset ovat luonnossa yleisesti tavattuja hyönteisspesifisiä viruksia. Viimeisten 
vuosikymmenten aikana niitä on laajasti hyödynnetty erilaisiin biotekniikan sovelluksiin. 
Kun virusten havaittiin ensimmäistä kertaa pystyvän siirtämään geenejä myös 
ihmissoluihin, on niitä sittemmin tutkittu paljon myös geeninsiirtotarkoituksia silmällä 
pitäen. Vaikka bakulovirus pystyykin siirtämään geenejä useisiin erilaisiin solutyyppeihin, 
viruksen liikkeistä näissä soluissa tiedetään vielä vähän. Myöskään reseptoria, jota virus 
hyödyntää ei ole aiemmin pystytty identifioimaan. 
Tämän tutkimuksen tarkoituksena oli tutkia yksityiskohtaisesti bakuloviruksen 
interaktiota ihmissolujen pinnan kanssa ja identifioida heparaanisulfaattiproteoglykaanien 
perheenjäsen, johon virus mahdollisesti ihmissoluissa sitoutuu. Tulostemme mukaan 
bakulovirus sitoutuu spesifisesti N- ja 6-O-sulfatoituun syndekaani-1 molekyyliin. Tämä 
viruksen ihmissoluissa käyttämä reseptori pystyttiin ensimmäistä kertaa selvittämään tässä 
tutkimuksessa. 
Koska bakulovirustransduktion lopputulos in vitro ei ainoastaan riipu käytetystä 
solutyypistä vaan myös transduktio-olosuhteista, halusimme tutkia kuinka erilaiset 
soluviljelymediumit vaikuttuvat virustransduktion tehokkuuteen. Tulostemme perusteella 
optimaalisen soluviljelymediumin (RPMI 1640) käyttö kasvatusmediumina johtaa viruksen 
lisääntyneeseen tumaan sisäänmenoon. Tämä lisääntynyt sisäänmeno perustuu solujen 
keskikokoisiin filamentteihin kuuluvan vimentiinin uudelleenjärjestymiseen.  
Koska jotkut ihmissolut ovat alttiimpia virusvälitteiselle geeninsiirrolle toisiin 
verrattuna, halusimme tutkia syitä, mitkä selittävät havaitut erot. Havaitsimme, että 
vähemmän permissiivisissä soluissa oli erilainen F-aktiinin, vimentiinin, PKCα ja PKCε 
ilmentyminen permessiivisimpiin soluihin verrattuna. Optimaalisen soluviljelymediumin 
(RPMI 1640) käyttö sai soluissa aikaan alentuneen synteniin ilmentymisen sekä erilaisen 
PKCα:n ja ε:n säätelyn. Tämän lisäksi niissä oli havaittavissa väljempi vimentiiniverkko. 
Solunsisäisiä kinaasiaktiivisuuksia tutkiessamme havaitsimme, että soluissa oli myös 
erilainen kinaasien säätely.  
Yhteenvetona voidaan todeta, että tämä työ tuo ilmi tärkeitä näkökulmia bakuloviruksen 
sitoutumiseen ja liikkeisiin ihmisoluissa vaikuttavista tekijöistä. Tämän lisäksi työssä 
onnistuttiin ensimmäistä kertaa tunnistamaan bakuloviruksen ihmisoluissa käyttämä 
pintareseptori, syndekaani-1. 
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1 Introduction 
Gene therapy is a novel approach aiming to treat inherited or acquired diseases and 
pathologic conditions by means of replacing a deficient gene or introducing a new one to 
target cells, tissues or the affected organ with the help of a gene transfer vector (Verma & 
Weitzman 2005). The vectors generally used for the delivery purposes are different types of 
viruses or DNA based plasmids. DNA based plasmids are normally delivered by direct 
injection or with the aid of liposomes or nanoparticles. The advantage of the plasmid based 
gene transfer system is that they are safe to use. However, the transfection efficiency is in 
most cases relatively low and transient thus limiting their use in cases where efficient long 
term expression is needed (Verma & Weitzman 2005). Today, the most efficient gene delivery 
vehicles are based on viruses which have a natural preference to enter and expand in 
mammalian cells. Within gene therapy applications, the most commonly used viruses today 
include retroviruses, herpesviruses, adenoviruses and adeno-associated viruses (Verma & 
Weitzman 2005). These are either categorized into RNA (e.g. retroviruses) or DNA based 
viruses (e.g. adeno and adeno-associated viruses, AAV). Where the adenoviruses lead to 
transient gene expression, retroviruses have the possibility to integrate within the host 
genome. AAVs and herpesviruses are generally thought to remain in the cells in episomal 
from. 
Baculoviruses are insect-specific viruses widespread in the nature. In recent decades, they 
have been widely utilized in protein production but have also proved to be useful as gene 
transfer vehicles in a wide variety of mammalian cells (Kost et al. 2005). The viruses have 
multiple important advantages such as their large transgene capacity, safety and the 
capability to transduce both dividing and non-dividing cells (Airenne et al. 2013). The 
transduction results in transient gene expression and is not cytotoxic to the target cells. Since 
baculoviruses are non-pathogenic for humans, vertebrates do not have a pre-existing 
immunity against them (Strauss et al. 2007). Many of these advantages are valued properties 
of viral vectors aimed to be used in different gene therapy applications. Though the 
baculovirus has been widely studied in the mammalian cell environment, much of the steps 
of the virus´s entry in non-target cells, starting from the initial binding and ending in 
transgene expression in the host cell nucleus, are mostly unknown. In this work, we focused 
on further determining and understanding the events leading to efficient transduction in 
mammalian cells. Understanding the changes and responses of the cells during transduction 
can not only help to engineer improved baculoviral vectors for future gene transfer purposes, 
but can also help in the selection of the most suitable targets for baculovirus-mediated gene 
delivery.   
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2 Review of the Literature 
2.1 BACULOVIRUSES 
Baculoviruses are large (40–60 nm x 230–385 nm) enveloped insect-specific viruses with a 
double-stranded circular supercoiled DNA genome of approximately 80–180 kbp in size 
encoding for 90-180 genes (Summers & Anderson 1972; Rohrmann 2011; Okano et al. 2006). 
They naturally infect lepidoptera, hymenoptera and diptera hosts and today, over 600 members 
are known (Okano et al. 2006). Baculoviruses are very commonly encountered in nature 
and are also used as natural control agents in agriculture to protect human food crops from 
pests (Kost & Condreay 2002; Summers 2006). The viruses can be divided into two major 
groups based on their occlusion body morphology: nucleopolyhedroviruses (NPV) and 
granuloviruses (GV). GVs contain only one nucleocapsid per envelope whereas NPVs 
contain either single (SNPV) or multiple (MNPV) nucleocapsids per envelope (Figure 1). 
The occlusion bodies consist of a crystalline matrix composed of polyhedrin in NPVs and 
granulin in GVs. Both of these occlusion bodies are very stable and can resist most 
environmental conditions (Rohrmann 2011). According to the new classification, the viruses 
of Lepidoptera are further divided into Alpha- and Betabaculoviruses including NPVs and 
GVs, respectively, and those infecting Hymenoptera and Diptera are named Gamma- and 
Deltabaculoviruses (Jehle et al. 2006). 
 
 
Figure 1. Morphology of nucleopolyhedrovirus and granulovirus. Polyhedral occlusion bodies of 
nucleopolyhedroviruses contain multiple nucleocapsids and are further categorized as SNPV or 
MNPV. Granular occlusion bodies of granuloviruses contain only one nucleocapsid. 
 
In nature, baculoviruses (NPVs) have a biphasic infection cycle and the virions are 
present as two types; occlusion-derived virions (ODV) and budded virions (BV) (Blissard & 
Rohrmann 1990). They are similar in their nucleocapsid structure but differ in the origin 
and composition of their envelopes as well as their roles in the virus infection cycle. Where 
the budded virus spreads the infection within the host, the occlusion-derived virus spreads 
it between insect hosts and is also responsible for the primary infection (O´Reilly et al. 
1994). The primary infection cycle of a baculovirus starts when the highly stable polyhedrin 
crystalline protein matrix coated ODVs enter an insect from a virus contaminated plant 
4 
 
 
(Herniou et al. 2003; Szewczyk et al. 2006) (Figure 2). The polyhedrin matrix dissolves in the 
alkaline environment of the insect midgut and releases the ODVs which then fuse with the 
columnar epithelial cells of the digestive tract (Granados & Lawler 1981). After cellular 
entry, the nucleocapsids are transported into the nucleus where transcription and virus 
replication take place. Baculovirus infection is divided into three phases and the viral 
genome replication stage is known as the early phase (0-6 h). At the later stage of infection, 
also known as the late phase, viral late genes are expressed and the machinery of the host 
cell is recruited to produce budded virus particles, which bud out of nucleus within 
vesicles. This phase extends from 6 h to 24 h post infection. The nucleocapsids are released 
from their vesicles on their way to the cell membrane and exit the cell from its basolateral 
side acquiring an envelope from the cell membrane. These viruses then enter other insect 
cells via adsorptive endocytosis (Volkman & Goldsmith 1985; Wang et al. 1997) and further 
spread the infection within the larva through the tracheal system and hemolymph (Keddie 
et al. 1989; Federici 1997). In the very late phase of infection (18-24 to 72 h) the production of 
budded viruses decreases and occluded virions are produced. The death of the larva results 
in the release of ODVs in the environment and facilitates the beginning of a new infection 
cycle.  
 
Figure 2. Infection cycle of baculovirus. The infection cycle begins when ODVs fuse with the 
columnar epithelial cells of the insect midgut. In the cells, the nucleocapsids are transported to 
the nucleus and the replication of the viral genome starts. At the later stage of the infection 
budded viruses are produced which spread the infection systemically in the larvae. Modified 
from (Ghosh et al. 2002). 
 
ODV and BV differ not only in their roles in the infection cycle but also in their structure 
(Figure 3). The polyhedrin coated matrix surrounding ODVs is missing from the BV virion. 
The different virions have also different lipid and protein profiles within their envelopes 
(Braunagel & Summers 1994). The structural difference is based on the origin of the 
envelopes. Where the ODV envelope is derived from the nuclear membrane of the insect 
cell, the BV envelope is acquired from the host cell membrane (Funk 1997). The budded 
virus contains, along with host cell proteins, viral coded proteins which are not present in 
5the  ODV  form  (Braunagel  &  Summers  1994).  One  of  these  is  the  major  envelope
glycoprotein gp64 (Oomens et al. 1995) which forms spike-like peplomers in the rod end of
the virus envelope focused on the side of the virus budding from the insect cells (Hefferon
et al. 1999). Gp64 is crucial in the progress of the infection since it is responsible for the
attachment (Hefferon et al. 1999) and entry (Blissard & Wenz 1992) into further host cells.
Gp64 controls the pH-dependent membrane fusion which releases the nucleocapsid into
the cell (Blissard & Wenz 1992). Gp64 is also necessary for the production of infective
viruses and important in the virus egress from the cells (Oomens & Blissard 1999). Though
ODVs and BVs are responsible for different stages of the infection they share some similar
structural  features.  They  both  have  similar  DNA  and  nucleocapsid  structures  and  both
virions contain also the main nucleocapsid proteins vp39, p80 and p24 as well as the DNA
binding protein p6.9 (Funk et al. 1997). P6.9 and vp39 together with vp1054 and vp91 are
conserved structural proteins among all baculoviruses (Okano et al. 2006).
Figure 3. Schematic of budded virus and occlusion derived virus. Budded virus has spike-like
peplomers in the rod end of the virus which consist of gp64. Capsid protein vp39 is present in
both forms of the virus.
The prototype baculovirus is considered to be the ?-baculovirus Autographa californica
multiple nucleopolyhedrovirus (AcMNPV) (Jehle et al. 2006). It is a large virus which has a
rod shape appearance (Blissard & Rohrmann 1990). It is known to infect over 30 members
of the Lepidoptera order (Carbonell et al. 1985). The virus has been widely studied and the
sequenced genome of the virus is about 134 kbp in size encoding around 154 proteins
(Ayres et al. 1994; Chen et al. 2013). The most important structural proteins of the budded
form of  the  virus  are  the  DNA binding protein  p6.9,  the  main nucleocapsid protein  vp39
and the envelope protein gp64 (Braunagel & Summers 1994).
2.1.1 Baculovirus: biotechnology applications
The budded form of AcMNPV has been widely utilized in the baculovirus expression
system and has become one of the most commonly used methods to produce recombinant
proteins today (Kost et al. 2005). The insect cells commonly used in protein production are
generally derived from Spodoptera furgiperda (Sf9 and Sf21AE) and Trichoplusia ni (BTI-Tn-
5B1-4) cells (Vaughn et al. 1977; Ikonomou et al. 2003). The advantage of the system is that
nearly all necessary post-translational modifications take place excluding the N-
glycosylation route, which is different between insect and mammalian cells. The production
system is fast, easy and the scalability of the system allows the production of large
quantities of the desired protein requiring that the genes are placed under the control of the
strong AcMNPV polyhedrin (polh) or p10 promoter (Hu 2005; O´Reilly et al. 1994). Also
promoters of the virus major capsid protein gene (vp39), the basic 6.9 kD protein gene, and
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the viral ie1 gene can be utilized (O´Reilly et al. 1994; Miller 1993). In addition to 
production of proteins (Kost et al. 2005), the baculovirus expression system has been 
applied for drug screening (Kost et al. 2007), eukaryotic surface display (Oker-Blom et al. 
2003), vaccination (Hu et al. 2008) and production of other viruses such as AAVs (Urabe et 
al. 2002) and lentiviruses (Lesch et al. 2008), as well as viral like particles (Noad & Roy 
2003). Today, even the FDA and EMA accepted commercial baculovirus technology based 
vaccine products e.g. Cervarix®, Provenge® and FluBlok® (Hitchman et al. 2009; Lin et al. 
2011; McPherson 2008) are available in the market.  
2.1.2 Baculoviruses as gene delivery vectors 
Though baculoviruses are highly insect specific, it was proven especially in the 1980´s that 
AcMNPV is able to non-productively enter into vertebrate cells (Volkman & Goldsmith 
1983). However, only in the 1990’s was it shown that AcMNPV can also be used for efficient 
gene delivery into vertebrate cells, especially hepatocytes, if containing an expression 
cassette having a target cell functional promoter (Hofmann et al. 1995; Boyce & Bucher 
1996). Since then, the virus has been utilized in different types of in vitro and ex vivo gene 
transfer applications in many types of mammalian cells. These include a broad spectrum of 
cells of human, monkey, porcine, bovine, rabbit, rat, mouse, hamster, fish, sheep and avian 
origin (Table 1). In addition, baculoviral vectors have been successfully used in induced 
pluripotent stem cells (iPS) and other stem cell applications (Pan et al. 2013; Takata et al. 
2011; Lei et al. 2011). Within all the studied cell types, the best targets have proven to be the 
ones from hepatic and kidney origin, whereas the poorest targets have been found to be 
from the hematopoietic origin (Airenne et al. 2013).  
Baculovirus has been shown to stimulate host antiviral immune responses in 
mammalian cell lines by promoting cytokine production (Abe et al. 2003; Beck et al. 2000; 
Gronowski et al. 1999; Abe et al. 2005; Abe et al. 2009; Boulaire et al. 2009; Chen et al. 2009; 
Han et al. 2009; Wilson et al. 2008). The virus exposure has been shown to result in the 
activation of tumor necrosis factor , interleukin 1 , and interleukin 1  expression as well 
as in the production of interferons (Beck et al. 2000; Gronowski et al. 1999). The 
involvement of toll-like receptors was suggested when AcMNPV was shown to induce the 
secretion of tumor necrosis factor  and interleukin 6 as well as increased expression of 
activation ligands in murine macrophages (Abe et al. 2003). The role of toll-like receptor 9 
and MyD88-dependent signaling pathway on activation of immune cells via baculoviral 
DNA has also been demonstrated (Abe et al. 2005). Viral DNA has also been shown to 
promote humoral and CD8+ T-cell adaptive responses and induce maturation of dendritic 
cells as well as the production of inflammatory cytokines (interferon αβ) against 
coadministered antigen (Hervas-Stubbs et al. 2007). However, other viral components and 
recognition pathways, e.g. toll-like receptor 3 (Chen et al. 2009) and toll-like receptor-
independent routes (interferon regulatory factors 3 and 7) (Abe et al. 2003; Abe 2012) are 
also involved. The induction of antiviral effects in mammalian cells is shown to be cell type 
dependent (McCormick et al. 2004; Suzuki et al. 2010; Han et al. 2009). 
Several aspects support the use of baculoviruses as gene delivery vehicles. The most 
important one being the safety of these vectors, since the viruses have not been linked to 
any diseases outside the phylum Arthropoda (Burges et al. 1980). The viruses are not able 
to replicate in mammalian cells, thus offering a non-cytotoxic approach for gene transfer 
purposes in mammalian cells. The baculovirus is able to carry large amounts of foreign 
DNA (up to 38 kbp) (O´Reilly et al. 1994) and it is easy to manipulate (O´Reilly et al. 1994). 
The use of baculoviruses does not limit the investigator to dividing mammalian cells since 
the virus can also transduce nondividing cells (van Loo et al. 2001). The outcome of the 
virus transduction is transient, gene expression lasting from one to two weeks and does not 
pose an insertional mutagenesis risk. Transgene expression starts around 6 h after 
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transduction and the highest level of expression is normally achieved at 24-48 h after 
transduction (Boyce & Bucher 1996; Haeseleer et al. 2001). 
 
Table 1. Baculoviral transduced cell types from different origin.  
Species Cell lines  References Primary cells References 
Human CHP212, DLD-
1, ECV-304, 
FlC4, hCSMC, 
HEK293, Hela, 
HepG2, Huh7, 
IMR32, KATO-
III, MRC5, 
MG63, MT-2, 
SAOS-2,SK-N-
MC, WI38,  
W12, 143TK 
(Airenne et al. 2009; 
Barsoum et al. 1997; 
Boyce & Bucher 1996; 
Kost & Condreay 
1999; Clay et al. 
2003; Grassi et al. 
2006; Ho et al. 2005; 
Hofmann et al. 1995; 
Ma et al. 2000; Sarkis 
et al. 2000; Shoji et 
al. 1997; Song & 
Boyce 2001; Song et 
al. 2003; Tani et al. 
2001) 
Neural cells, 
pancreas β-cells, 
bonemarrow 
fibroblasts, 
keratinocytes, 
hepatocytes, 
mesenchymal stem 
cells, hepatic 
stellate cells, 
prostate cells  
(Sarkis et al. 2000; Ma et 
al. 2000; Condreay et al. 
1999; Boyce & Bucher 
1996; Hofmann et al. 1995; 
Ho et al. 2005; Gao et al. 
2002; Swift et al. 2013; 
Gamble & Barton 2012; 
Nicholson et al. 2005) 
Rabbit RAASMC 
 
(Airenne et al. 2009) Intervertebral disc 
cells, chodrocytes 
 
(X. Liu et al. 2006; Lee et 
al. 2009) 
Monkey COS-1, CV-1, 
Vero 
(Aoki et al. 1999; 
Condreay et al. 1999; 
Tani et al. 2001; Yap 
et al. 1997)  
Hepatocytes (Martyn et al. 2007) 
Rodent CHO, BHK, 
RGM- I, PC12, 
N2a, L929 
(Aoki et al. 1999; 
Boyce & Bucher 1996; 
Ma et al. 2000; Sarkis 
et al. 2000; Shoji et 
al. 1997; Tani et al. 
2001)  
Rat hepatocytes, 
rat chondrocytes, 
rat liver stellate 
cells, mouse kidney 
cells  
 
 
(Boyce & Bucher 1996; Hsu 
et al. 2004; Gao et al. 
2002; Liang et al. 2004; 
Beck et al. 2000) 
Porcine CPK, FS-L3, 
PK-15 
(Aoki et al. 1999) Coronary artery 
smooth muscle 
cells 
(Grassi et al. 2006) 
Bovine MDBK, BT (Aoki et al. 1999) - - 
Sheep FLL-YFT (Aoki et al. 1999) - - 
Fish EPC, TO-2, 
CHH-1, CHSE-
214, HINAE, 
MES1 
(Leisy et al. 2003; 
Yokoo et al. 2013; 
Huang et al. 2011; 
Yan et al. 2009) 
- - 
Avian Df-1, 
DT40,HD11 
(Lu et al. 2007; Han 
et al. 2010) 
Duck embryonic 
cells, chicken 
myoblast and 
embryonic 
fibroblast cells 
(Song et al. 2006; Ping et 
al. 2006) 
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2.1.3 Factors affecting baculovirus transduction  
The outcome of baculovirus transduction in vitro is generally cell dependent but can also be 
influenced by modifying cell culture conditions, optimizing the expression cassette within 
the virus and improving the virus entry by pseudotyping. Changes in the physical 
properties such as pH, transduction time, temperature and transduction volume have all 
been seen to have an effect on the outcome of the transduction (Hsu et al. 2004; Airenne 
2009). Since baculoviruses are considered non-cytotoxic to mammalian cells, multiple re-
additions of the virus can be safely performed to pursue the enhanced expression levels 
(Hu et al. 2003; Wang et al. 2005). The use of chemical substances, such as the histone 
deacetylace inhibitors sodium butyrate and tricostatin A have also been shown to lead to 
improved transgene expression (Condreay et al. 1999), whereas the microtubule interfering 
substances nocodazole or vinblastine have been shown to aid baculovirus transport to the 
nucleus (van Loo et al. 2001; Salminen et al. 2005).  
Promoters active in mammalian cells, such as CMV (cytomegalovirus), RSV (Rous 
sarcoma virus) or CAG (chicken β-actin promoter), are generally used to drive the 
baculovirus mediated transgene expression since the virus´s own promoters are mostly 
inactive in non-target cells (Stanbridge et al. 2003). Genetic engineering by incorporation of 
tissues specific promoters into baculoviral vectors has been use to target transgene 
expression to certain tissues and cells (Park et al. 2001; Li et al. 2005; Wang & Wang 2006; 
Guo et al. 2011) whereas inducible promoters (Guo et al. 2011; McCormick et al. 2004) have 
been used to control the level of the expression. Incorporation of the woodchuck hepatitis 
post-transcriptional regulatory element (WPRE) into the baculovirus expression cassette 
has been shown to lead to enhanced transgene expression (Mähönen et al. 2007). Since 
baculovirus transduction is transient, can the incorporation of elements enabling long term 
expression from other viruses, such as from AAV (Palombo et al. 1998; Wang & Wang 
2005), Epstein-Barr virus (Shan et al. 2006) and the transposon Sleeping beauty (Luo et al. 
2012), be used to prolong the expression.  
Pseudotyping is based on the modification of viral envelope proteins in order to enhance 
virus tropism or improve transduction efficiency. Since gp64 is essential in the infection of 
insect cells and transduction of mammalian cells (Liang et al. 2005), addition of extra copies 
of gp64 on the viral envelope has been shown to lead to better transduction efficiency (Tani 
et al. 2003). Gp64 has been also modified to target different peptides or proteins, e.g. human 
immunodeficiency virus-1 (HIV-1) glycoprotein 120 (Oker-Blom et al. 2003; Boublik et al. 
1995). Vesicular stomatitis virus envelope G-protein (VSVG) has been used not only to 
broaden virus tropism, but also to enhance transduction (Barsoum et al. 1997; Kaikkonen et 
al. 2006; Kitagawa et al. 2005; Pieroni et al. 2001; Tani et al. 2003). Transduction efficiency 
has also been successfully improved by directing the expression with ligands (Matilainen et 
al. 2006; Mäkelä et al. 2006; Ojala et al. 2001; Ojala et al. 2004; Oker-Blom et al. 2003; 
Riikonen et al. 2005; Räty et al. 2004). Other surface modifications that have aided in virus 
transduction are the incorporation of avidin (Räty et al. 2004), biotin (Kaikkonen et al. 
2008), lymphatic homing peptide (Mäkelä et al. 2008) and polymer coating with polyethyl 
glycol (Kim et al. 2006; Kim et al. 2009; Kim et al. 2007; Kim et al. 2010) or polyethylenimine 
(Yang et al. 2009).  
2.1.4 In vivo applications of baculoviruses 
The first in vivo gene transfer attempts with baculoviruses were performed into the livers of 
rats and mice in the late 1990´s (Sandig et al., 1996). Subsequently several different types of 
animal models (Table 2), including ones of mouse, rat and rabbit origin, have been used to 
study gene transfer capabilities of the virus in the tissue environment. Though 
baculoviruses don´t suffer from pre-existing immunity in humans or other vertebrates 
(Strauss et al. 2007), the virus is quickly inactivated by the components of the serum 
complement (Hofmann et al. 1995). The inactivation results when the classical (Hofmann & 
9 
 
 
Strauss 1998; Georgopoulos et al. 2009) and the alternative (Hoare et al. 2005) pathways are 
activated. As a result of the complement susceptibility of the baculoviral virion, the best in 
vivo targets have been found to be the immunopriviledged tissues such as the eye 
(Kinnunen et al. 2009) or the brain (Wu et al. 2009). Accordingly, studies have revealed that 
the central nervous system and testis are also good targets for the virus (Airenne et al. 
2010). Due to the neutralizing capabilities of complement, approaches to overcome its effect 
have included the use of complement inactivators, e.g. soluble complement receptor type 1 
(Hoare et al. 2005), cobra venom factor (Sarkis et al. 2000) and compstatin (Georgopoulos et 
al. 2009) which have all proven their usefulness in protecting the virus from inactivation. 
Shielding the viruses with complement interfering factors, such as decay acceleration factor 
(Huser et al. 2001), factor H like protein, C4b-binding protein and membrane cofactor have 
also aided in the protection of the virus from the immune system (Kaikkonen et al. 2010). 
 
Table 2. In vivo gene transfer studies performed with baculovirus.  
Species Tissue Reference 
Mouse Brain, testis, eye, abdomen, 
muscle, liver, lung, systemic 
administration, 
nasopharyngeal carcinoma, 
tumors 
(Wu et al. 2009; Sarkis et al. 2000; Tani et 
al. 2003; Park et al. 2009; Haeseleer et al. 
2001; Huang et al. 2008; Strauss et al. 
2007; Pieroni et al. 2001; Hofmann & 
Strauss 1998; Kircheis et al. 2001; 
Kaikkonen et al. 2010; Nishibe et al. 2008; 
Kim et al. 2006; Hoare et al. 2005; Yang et 
al. 2009; Pan et al. 2010; Mäkelä et al. 
2008; Wang et al. 2008; Balani et al. 
2009; Kitajima et al. 2008; Luo et al. 
2013; Molinari et al. 2011; Luo et al. 2012) 
Rat Brain, liver, eye, dorsal 
root ganglia, biodistribution 
analysis, heart 
(Laitinen et al. 2005; Kaikkonen et al. 
2006; Räty et al. 2006; Li et al. 2004; 
Lehtolainen et al. 2002; Sarkis et al. 2000; 
Wang & Wang 2006; Wang & Wang 2005; 
B. H. Liu et al. 2006; Wang et al. 2006; 
Ong et al. 2005; Li et al. 2005; Paul et al. 
2012; Lesch et al. 2011) 
Rabbit Artery, muscle, intervertebral 
disc, eye 
(Airenne et al. 2009; Kaikkonen et al. 
2006; X. Liu et al. 2006; Kinnunen et al. 
2009; Heikura et al. 2012) 
Honeybee Several tissues (Ando et al. 2007) 
Fish Embryo (Wagle & Jesuthasan 2003; Wagle et al. 
2004) 
Dog Femoral artery (Paul et al. 2013) 
Butterfly Wings (Dhungel et al. 2013) 
Chicken Intravenous inoculation (Luo et al. 2013) 
2.1.5 Production of baculoviruses 
Baculoviruses are produced in insect cells, today most commonly in the Sf-9 cell line, 
originally derived from fall armyworm (Spodoptera frugiperda) ovarian tissue (Vaughn et 
al. 1977). The most generally used method to generate baculoviruses today relies on the 
Bac-To-Bac transposon based system (Invitrogen). The system utilizes a site-specific 
transposition, Tn7 to insert foreign genes into a bacmid DNA (baculovirus genome) 
propagated in E. coli cells (Luckow et al. 1993). In practice, the transgene is inserted into a 
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donor plasmid which is transferred into a baculovirus shuttle vector by site-specific 
transposition in E. coli. The recombinant bacmid containing colonies are selected by blue-
white color screening with LacZ, the bacmid is isolated and used to transfect insect cells. 
Pure recombinant primary viruses are achieved in 7 to 10 days and the production 
normally results in high titers of the virus (O´Reilly et al. 1994). The system has been further 
modified to reduce background and is known as the BVBoost system (Airenne et al. 2003). 
The virus production protocol is simple and can be performed at biosafety level 1 (Airenne 
et al. 2011; O´Reilly et al. 1994; Burges et al. 1980). Recent development in membrane-based 
technology purification also enables virus production at high-scale with good 
manufacturing based practice (Vicente et al. 2009).  
2.1.6 Entry and intracellular movements of baculovirus 
Though the binding and entry of baculoviruses into mammalian cells have been studied in 
many types of cells, much of the molecular details remain still unknown (Airenne et al. 
2013). Due to the wide tropism of the virus it has been previously speculated that 
baculoviruses utilize non-specific electrostatic interactions and attach to the surface of 
mammalian cells via a general cell surface molecule, such as a phospholipid or a heparan 
sulfate proteoglycan (HSPG) (Wu & Wang 2012; O’Flynn et al. 2013; Duisit et al. 1999; Tani 
et al. 2001). It was previously shown that the removal of HSPGs with heparinase treatments 
leads to a reduction in baculovirus binding (Duisit et al. 1999). Recently it was also shown 
that baculovirus has a heparin binding motif within gp64 (Wu & Wang 2012). Both of these 
findings support the possible role of HSPGs in cell surface binding. However, gp64 has also 
been shown to interact with cell surface phospholipids (Tani et al. 2001; Kamiya et al. 2010; 
Kataoka et al. 2012; O’Flynn et al. 2013) suggesting that the baculovirus entry is a multistep 
process requiring several cell surface factors.  
The actual internalization of the baculovirus has been shown to be mediated by lipid 
rafts (Kataoka et al. 2012; O’Flynn et al. 2013) and is associated within cholesterol rich areas 
(Laakkonen et al. 2009; Kataoka et al. 2012; O’Flynn et al. 2013). Internalization has also 
been shown to lead to extensive membrane ruffling of the cell surface (Laakkonen et al. 
2009). The entry mechanism is thought to be endosytosis, either pinocytosis or phagocytosis 
(Laakkonen et al. 2009; Matilainen et al. 2005; Kataoka et al. 2012) since none of the clathrin, 
caveolae-, flotillin-, GPI-anchored protein-enriched- or IL-2R-mediated endocytosis routes 
were seen to be involved (Laakkonen et al. 2009). Other mechanisms, such as clathrin 
mediated endocytosis as well as macropinocytosis have also been suggested (van Loo et al. 
2001; Kataoka et al. 2012; Matilainen et al. 2005) highlighting the fact that several different 
entry routes can exist and entry can be cell type dependent. Virus uptake has been shown 
to rely on actin and the trafficking is regulated by Ras homolog gene family member A 
(RhoA), ADP-ribosylation factor 6 (Arf6) and dynamin (Laakkonen et al. 2009).  
Following cell entry, the virus is transported within vesicles until the pH-dependent 
fusion of the viral envelope with the endosome releases the capsid into the cytoplasm 
(Figure 4) (Laakkonen et al. 2009; Blissard 1996; Matilainen et al. 2005). The escaped 
nucleocapsid is transported in the cell with the aid of actin filaments and the nucleocapsid 
enters the nucleus via nuclear pores (Goley et al. 2006; Ohkawa et al. 2010; Au et al. 2012). 
When the virus is in the nucleus, the nucleocapsid disassembles and the viral DNA is 
released (Kukkonen et al. 2003; van Loo et al. 2001; Laakkonen et al. 2008; Au et al. 2012). In 
the nucleus, baculovirus virions localize into discrete foci in the nuclei and induce 
accumulation of promyelocytic leukemia (PML) nuclear bodies (Laakkonen et al. 2008). 
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Figure 4. Baculovirus entry mechanism in insect and in mammalian cells. Baculovirus binds to 
the surface of the cells and is then internalized. In the cell, the virus escapes from the 
endosome and is transported to the nucleus. Modified form (Stanbridge et al. 2003). 
 
2.2 ECHOVIRUSES 
 
Echovirus-1 (EV-1) is a small nonenveloped single-stranded RNA virus which belongs to 
Enterovirus genus of Picornaviridae family. The virus is 24-30 nm in size and the genome is 
approximately 7.5 kilobases long. 32 different serotypes of enteroviruses are known. They 
comprise a large group of common human pathogens which cause a wide range of different 
illnesses from minor fever to aseptic meningitis, encephalitis, paralysis and myocarditis 
(Dahllund et al. 1995). EV-1 infects a wide variety of α2β1 integrin expressing cells as the 
virus uses the integrin as its receptor (Bergelson et al. 1992). The virus life cycle begins with 
attachment of the virus to the cell surface receptor, entry of the virus into the cell and 
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finally into the release of the single-strand, positive-sense RNA genome from the capsid 
into the cytoplasm, where the translation and replication of the genome takes place. EV-1 
causes the clustering of its receptor at the cell surface which then leads to virus 
internalization primarily via macropinocytosis. The internalization is dependent on Rac1, 
Pak1, PLC, and protein kinase Cα activation. This is followed by gradual accumulation of 
the viruses in perinuclear endosomes (Marjomäki et al. 2002; Upla et al. 2004; Karjalainen et 
al. 2008). 
 
2.3 CELL CYTOSKELETON  
 
The cell cytoskeleton is a dynamic network which adapts to the environmental and internal 
changes of the cell. The components of the cytoskeleton are responsible for connecting the 
cell to the environment as well as organizing the contents of the cell and enabling the cell to 
move and change shape (Wickstead & Gull 2011). The cytoskeleton consists of three main 
types of filaments; actin filaments, microtubules and intermediate filaments (Figure 5). The 
most important differences between these filaments are their physical properties such as 
stiffness, polarity, assembly and the type of molecular motors which they associate with 
(Fletcher & Mullins 2010). These cytoskeletal polymers are controlled by several regulatory 
proteins which are responsible for different tasks. These include filament formation, growth 
determination and promotion, depolymerization and disassembly, crosslinking, 
stabilization and organization into high-order network structures (Fletcher & Mullins 2010). 
 
 
Figure 5. Cytoskeletal elements of the cell. Blue represents microtubules, green actin and red 
intermediate filaments. Modified from (Godsel et al. 2008). 
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2.3.1 Actin 
Actin, also called microfilament (MF), has many important roles within the cells.  Though 
actin is present throughout the cytosol, it is predominantly found near the plasma 
membrane (Fletcher & Mullins 2010). Actin can be found in cells either as free monomeric 
actin or linear filament. Monomeric subunits of actin are called globular actin (G-actin). 
When G-actins polymerize they form a fiber which is called filamentous actin (F-actin). All 
actin monomers have the same head-to-tail assembly in the actin fiber which thus shows 
polarity. Actin filaments have a fast growing plus-end and a slow growing minus-end. In 
cells, filamentous actin has a double-stranded helix appearance and the fibers are 
approximately 7-9 nm in diameter and several micrometers in length (Fletcher & Mullins 
2010). Actin filaments are found in cells in bundles consisting of aligned long filaments and 
three-dimensional networks of branched actin filaments (Vignaud et al. 2012). Actin 
polymerization requires adenosine triphosphate and is reversible. The assembly and 
disassembly of actin filaments is regulated by actin-binding proteins such as Arp2/3 
(Cooper & Schafer 2000). Actin interacts with motor protein myosins which move towards 
the extremities of the filaments (Vignaud et al. 2012). The polarity of actin has an important 
role not only in the actin assembly but also in myosin movement (Cooper 2000).  
2.3.2 Microtubules 
Microtubules (MTs) are dynamic hollow rods (25 nm in diameter) in which 13 
protofilaments are assembled around a hollow core in parallel orientation. Microtubules 
consist of tubulin which is formed of globular α/β tubulin dimers. Tubulin heterodimers 
assemble into the same orientation thus leading to the polarity of the microtubules. The 
plus-ends have a higher tendency to polymerize or depolymerize than the minus-ends 
(Radtke et al. 2006). Microtubules are found in cells in bundle like structures. They have an 
important role in moving organelles in the cytoplasm with the aid of motor proteins. The 
main microtubule associated motor proteins are dynein and kinesin. Within a cell, the 
minus ends of the microtubules are anchored to the microtubule-organizing center, the 
centrosome, whereas the plus ends are projected towards the cell surface. Microtubules 
form a mitotic spindle during cell mitosis as they separate and distribute the chromosomes 
to daughter cells (Cooper 2000).  
2.3.3 Intermediate filaments 
Intermediate filaments (IF) comprise a big family of fibrous, non-polarized structurally and 
sequentially related proteins (Herrmann et al. 2009). They are coil-like polymers which 
mainly have a structural role within the cell. They participate in maintaining the cell shape 
and in anchoring cellular organelles by forming a network throughout the cell. The size of 
the IFs is 10 nanometers on average and each intermediate filament contains approximately 
eight protofilaments wound around each other to form a ropelike appearance. All IF 
proteins have a central α-helical rod domain. The expression and the types of IFs expressed 
are dependent on the cell function (Fuchs & Weber 1994). IFs are divided into six different 
groups (Table 3). Type I IFs are acidic keratins and type II basic or neutral keratins. Type III 
IFs include vimentin, desmin, glial fibrillary acidic protein and peripherin. Type IV IFs are 
neurofilament proteins and α-internexin. Type V nuclear lamins and type VI nestin 
(Doherty & McMahon 2008). IFs dynamics, organization and distribution are modified by 
phosphorylation (Omary et al. 2006). 
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Table 3. IF proteins and their distribution.  
 
IF protein Type Distribution 
Keratin I Epithelia 
Keratin (basic) II Epithelia 
Vimentin III Mesenchymal cell 
Glial Fibrillary Acidic Protein III Glial cells, astrocytes 
Peripherin III Peripheral neurons 
Neurofilament proteins IV Nervous system 
Lamins V Nuclear envelopes 
Nestin VI Embryonal cells 
 
Vimentin, highly conserved in all vertebrates, is the most widely expressed type III 
intermediate filament protein encountered in mesenchymal cells (Ivaska et al. 2007; 
Herrmann et al. 2009). Vimentin is usually found in fibroblasts, smooth muscle cells and 
white blood cells but is widely expressed in various other cell types as well (Katsumoto et 
al. 1990). The expression of vimentin varies during different developmental stages (Ivaska 
et al. 2007). Vimentin functions as an organizer in cell attachment, adhesion, migration and 
signaling and hence has a role in cell physiology, cellular interactions and organ 
homeostasis (Ivaska et al. 2007). Vimentin plays also a significant role in supporting and 
anchoring organelles in the cytosol since it is attached to the nucleus, endoplasmic 
reticulum and mitochondria (Katsumoto et al. 1990).  
Vimentin is regulated by phosphorylation and vimentin polymers are very dynamic in 
nature. The phosphorylation and dephosphorylation of vimentin leads to rapid exchange 
between assembled IF polymers and a small fraction of disassembled IF subunits (Eriksson 
et al. 2004). Rearrangement of vimentin in cells requires phosphorylation of the N-terminal 
domains by cellular kinases and leads to disassembly into tetrameric subunits (Eriksson et 
al. 2004). Phosphorylation is controlled by different protein kinase C (PKC) isoforms 
(Ivaska et al. 2007). Vimentin is phosphorylated at specific sites within the protein. Thr-457 
and Ser-458 are targeted by mitotic p37 kinase (Chou et al. 1991) and Ser-55 by Cdc2 (Chou 
et al. 1990). Ser-38 and Ser-71 are targeted by protein kinase A (PKA) and Rho kinase, and 
Ser-72 by PKA. These sites have a big impact in maintaining and regulating vimentin 
structure (Eriksson et al. 2004; Goto et al. 1998). Major targets for PKC are Ser-4, 6, 7, 8 and 9 
and Ser-33 and 50  (Eriksson et al. 2004; Ogawara et al. 1995) (Table 4). 
 
Table 4. Examples of vimentin phosphorylation sites.  
 
Protein kinase Ser phosphorylation site Reference 
Cdc2 55 (Chou et al. 1991; Tsujimura et al. 1994) 
PKC 33 (Ogawara et al. 1995; Takai et al. 1996) 
PKC 50 (Ogawara et al. 1995; Takai et al. 1996)  
Rho kinase, PKA 38 (Goto et al. 1998; Eriksson et al. 2004) 
Rho kinase, PKA 71 (Goto et al. 1998; Eriksson et al. 2004) 
PKA 72 (Eriksson et al. 2004) 
CaM kinase II 82 (Ogawara et al. 1995; Ando et al. 1991) 
15 
 
 
2.3.4 Viral delivery and the cytoskeleton 
The host cytoskeleton has an important role in the entry and replication of several different 
viruses (Smith & Enquist 2002). MFs and MTs have been proposed to participate in co-
operation during endocytosis where MFs help in the uptake of ligands via endocytosis and 
MT are involved in the regulation of trafficking between peripheral early endosomes and 
juxtanuclear late endosomes (Durrbach et al. 1996). Many viruses take advantage of the cell 
cytoskeleton by either directly interacting with the proteins or re-arranging them (Radtke et 
al. 2006). Multiple viruses have been shown to utilize cellular actin and microtubules and 
their associated motor proteins for different steps during their life cycle (Mercer et al. 2010). 
Some viral infections such as that caused by the African swine fever virus has been shown 
to cause microtubule-mediated vimentin rearrangement (Stefanovic et al. 2005). Recently a 
link between parvovirus and the role of vimentin in the viral escape from endosomes and 
during endosomal trafficking was demonstrated (Fay & Panté 2013). Vimentin has been 
shown to have an important role in vesicular membrane traffic and it is also found 
important in endolysosomal vesicle transport and positioning (Styers et al. 2004).  
 
2.4 HEPARAN SULFATE PROTEOGLYCANS 
 
Heparan sulfate proteoglycans (HSPGs) are a family of cell surface molecules which form 
the major components of the extracellular matrices (Kirkpatrick & Selleck 2007). HSPGs are 
also encountered in cell tissue compartments, intracellular granules and in the nucleus. 
HSPGs have a wide variety of functions and they take part in cell metabolism, transport, 
information transfer, support and regulation (Figure 6) (Sarrazin et al. 2011). HSPGs are 
composed of a core protein to which one or more long unbranched heparan sulfate (HS) 
glycosaminoglycan (GAG) disaccharide chains are covalently attached. The GAG chains are 
attached to the core protein onto specific serine residues through a tetrasaccharide linker. 
HS chains consist of approximately 40–300 sugar residues with a length of 20–150 nm 
(Sarrazin et al. 2011) and are composed of alternating N-acetylated or N-sulphated 
glucosamine units (N-acetylglucosamine [GlcNAc] or N-sulphoglucosamine [GlcNS]) and 
uronic acids (glucuronic acid [GlcA] or iduronic acid [IdoA]) (Bishop et al. 2007). Some 
HSPGs contain also chondroitin sulphate (CS)/dermatan sulphate that differs from HS in its 
sugars (N-acetylgalactosamine [GalNAc] and GlcA/IdoA), patterns of modification and 
types of glycans (N-linked and O-linked mucin-type chains) (Bishop et al. 2007). The 
number and sulfation state of the chains can vary according to the growth conditions, cell 
type and in response to growth factors (Sarrazin et al. 2011). The arrangement of negatively 
charged sulfate groups and the orientation of the carboxyl groups in the GAGs specify the 
location of ligand-binding sites (Sarrazin et al. 2011). HS is synthesized by 
glycosyltransferases of the exostosin family (Bishop et al. 2007) and the GAG chains are 
enzymatically polymerized in the Golgi and further modified by epimerization and 
sulfation. The processing of HS can also occur at the plasma-membrane with membrane 
bound endosulphatases (SULF1 and SULF2) which remove specific sulfate groups from the 
chains (Dhoot et al. 2001; Morimoto-Tomita et al. 2002).  
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Figure 6. Different functions of heparan sulfate proteoglycans in cells. HSPGs are involved in 
several different cellular functions such as: 1. Cell-cell cross talk, 2. Storage depot, 3. Barrier 
formation, 4. Basement membrane organization, 5. Cell adhesion and motility, 6. Cytoskeletal 
interactions, 7. Lysosomal degradation, 8. Endocytosis, 9. Secretory granules, 10. Transcellular 
transport, 11. Proteolytic shedding, 12. Heparanase cleavage, 13. Chemokine presentation, 14. 
Ligand-receptor clustering and signaling. Modified from (Sarrazin et al. 2011).  
 
HSPGs are divided in to three subfamilies: membrane-spanning proteoglycans 
(syndecans, betaglycan and CD44v3), glycophosphatidylinositol-linked proteoglycans 
(glypicans) and secreted extracellular matrix (ECM) proteoglycans (agrin, collagen XVIII 
and perlecan) (Bishop et al. 2007). Glypicans (GPCs) and syndecans (SDCs) are considered 
to form the two main families of HSPGs. Glypicans comprise of six members and carry only 
HS side chains. Glypicans are mostly found in epithelial cells and fibroblasts (Sarrazin et al. 
2011). Whereas the GPC´s HS chains are attached to the core protein close to the plasma 
membrane, SDC´s HS chains are attached at more peripheral sites (Christianson & Belting 
2013). 
Membrane HSPGs act as endocytic receptors for bound ligands and participate in 
endocytosis and vesicular trafficking by regulating the movement of molecules between 
intracellular and extracellular compartments (Kirkpatrick & Selleck 2007; Wittrup et al. 
2009). They also act as coreceptors for various tyrosine kinase-type growth factor receptors 
and cooperate with integrins and other cell adhesion molecules to facilitate cell–cell 
interactions and cell motility. HSPGs can bind various cytokines, chemokines, growth 
factors and morphogens (Sarrazin et al. 2011) thus serving as receptors for multiple 
different ligands. These are e.g. the fibroblast growth factor family, the transforming 
growth factor beta family, bone morphogenetic proteins, Wnt proteins and interleukins, as 
well as enzymes and enzyme inhibitors, lipases, apolipoproteins, ECM and plasma proteins 
(Bishop et al. 2007). Although some ligands bind directly to the HSPG core proteins, the 
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vast majority of them interact with the sulfated domains of the HS chains (Sarrazin et al. 
2011).  
2.4.1 Syndecans 
Syndecans comprise a conserved family of heparan- and chondroitin-sulfate carrying type 
1-transmembrane proteoglycans. Four syndecans are encountered in mammals; syndecans 
1-4, whereas invertebrates have only one (Bernfield et al. 1999; Rapraeger 2001; Couchmann 
et al. 2001). Each syndecan is composed of a short cytoplasmic domain, a single-span 
transmembrane domain and an extracellular domain with attachment sites for three to five 
HS or CS chains (Sarrazin et al. 2011). SDC-2 and SDC-4 have 2–3 HS chains whereas SDC-1 
and SDC-3 have 3–4 HS/1-2 CS chains (Sarrazin et al. 2011). HS and CS chains are on 
average 20 to 80 disaccharides long and the syndecan core protein is 20-45 kDa in size 
(Couchman 2003). HS binds several different types of ligands whereas the role of CS is less 
clear (Tkachenko et al. 2005). SDC-1 and -3 are considered to form a subfamily and SDC-2 
and -4 another based on their protein sequence homology (Bernfield et al. 1999; 
Couchmann et al. 2001). The short cytoplasmic domain of syndecans is divided into three 
regions: conserved regions 1 and 2 (C1 and C2) and a variable (V) region. The C1 domain is 
nearly identical in all four mammalian syndecans (Figure 7). It is thought to be involved in 
syndecan dimerization and in binding of several intracellular proteins e.g. tubulin, ezrin, 
Src kinase and cortactin (Kinnunen et al. 1998; Granés et al. 2000). The conserved C-
terminal C2 domain contains a postsynaptic density-95/disc large protein/zonula 
occludens-1 (PDZ)-binding site at the C-terminal end. Four syndecan-interacting PDZ 
domain–containing proteins are identified so far: syntenin, synectin, synbindin, and 
calcium/calmodulin-dependent serine protein kinase (Hsueh et al. 1998; Ethell et al. 2000; 
Shin et al. 2001; Gao et al. 2000; Grootjans et al. 1997; Cohen et al. 1998). The V domain is 
highly heterogeneous within the syndecan family and the syndecan-4 V-region includes 
e.g. a phosphatidylinositol-4,5-bisphosphate (PIP2) binding site that is involved in 
syndecan-4 dimerization (Shin et al. 2001). 
 
 
Figure 7. Different domains of syndecans.  
 
In addition to binding different ligands, syndecans can function also as coreceptors 
which attract and concentrate molecules and aid in the formation of ligand-receptor 
complexes either by a conformational change or by acting as a template which brings the 
ligand and its receptor together (Tkachenko et al. 2005). The syndecan transmembrane 
domains have a tendency to form dimers and/or oligomers. Although SDCs have a 
conserved transmembrane domain sequence, the homodimerization has been shown to be 
weak for SDC-1, strong for SDC-3 and SDC-4, and very strong for SDC-2 (Dews & 
Mackenzie 2007). Different levels of self-association suggest that dimerization of specific 
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SDC core proteins may play different roles in directing membrane clustering following 
ligand binding (Grembecka et al. 2006). 
The expression of syndecans varies depending on the cell type (Table 5) and the phase of 
development (Bernfield et al. 1992). SDC-1 is expressed early in development and is 
commonly found in epithelia and mesenchymal cells. It is also highly expressed in 
keratinocytes. SDC-2 is found on mesenchymal tissues, but also in liver and neuronal cells. 
SDC-3 is mainly expressed in neural cells but is also found in musculoskeletal tissues. SDC-
4 is highly expressed by epithelial and fibroblastic cells. It also represents the most widely 
expressed member being present in many different cell types (Kim et al. 1994).  
 
Table 5. Syndecans, the composition of their side chains and their distribution. 
 
Syndecan Side chains Distribution 
Syndecan-1 HS, CS Epithelial and mesenchymal cells 
Syndecan-2 HS Endothelial and neuronal cells, mesenchymal tissues 
Syndecan-3 HS, CS Neuronal and musculoskeletal tissue 
Syndecan-4 HS Ubiquitously expressed 
 
2.4.2 Syndecan endocytosis and recycling 
Endocytosis can roughly be segregated into clathrin dependent and independent 
internalization mechanisms and the latter can be further divided into caveolin mediated 
endocytosis, macropinocytosis and caveolin-independent pathways involving lipid rafts 
(Howes et al. 2010; Mercer et al. 2010). Syndecans undergo constitutive as well as ligand-
induced endocytosis (Williams & Fuki 1997; Belting 2003). The endocytosis appears to be 
clathrin, caveolin, and dynamin independent taking place in phospholipid- and cholesterol-
rich lipid-raft areas (Zimmermann et al. 2005; Wittrup et al. 2010; Fuki et al. 2000). 
Syndecan internalization is triggered by ligand or antibody clustering and it requires intact 
actin microfilaments as well as tyrosine kinases (Fuki et al. 1997). In the normal state, SDC 
is predominantly found in the nonraft compartments whereas clustering induces its 
movement to lipid rafts (Fuki et al. 1997; Tkachenko et al. 2004; Zimmermann et al. 2005; 
Tkachenko et al. 2006).  
The functions of the syndecans depend also highly on their cytoplasmic domains that 
generate connections with signaling and cytoskeletal molecules (Couchman, 2003) and with 
several PDZ proteins (Grootjans et al. 1997), kinases (Src and calcium/calmodulin-
dependent serine protein kinase) (Chen & Williams 2013) and PIP2 (Alexopoulou et al. 
2007). Often signaling occurs in collaboration with other cell-surface receptors (such as 
integrins) (Bishop et al. 2007). The raft-mediated endocytic pathway of SDC-1 is dependent 
on its MKKK motif located in the cytoplasmic domain. The MKKK motif also participates in 
ERK activation which further triggers the dissociation of SDC-1 from tubulin (Chen & 
Williams 2013). After the dissociation, Src kinases phosphorylate SDC-1 transmembrane 
tyrosyl residues and cytoplasmic regions. Tyrosine phosphorylation of SDC-1 triggers the 
recruitment of cortactin which further mediates actin-dependent endocytosis (Chen & 
Williams 2013).  
Although recycling of internalized syndecan has been observed, most syndecans end up 
in lysosomes where they undergo degradation by lysosomal proteases and exolytic 
glycosidases and sulfatases (Fransson et al. 1995; Zimmermann et al. 2005). Syndecan 
recycling is controlled by syntenin which interacts with the EFYA sequence in the C2 region 
of the syndecans (Grembecka et al. 2006). Syntenin PDZ domain interacts also with PIP2, 
which is involved in the regulation of the actin cytoskeleton and membrane trafficking. 
Syntenin PIP2 interaction controls Arf6-mediated syndecan recycling and is required for 
efficient exit of syndecan from Arf6 recycling endosomes. The interaction is also important 
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for the recycling of SDC/syntenin from the endosomal compartments to the cell surface 
(Zimmermann et al. 2005). 
 
2.4.3 Viral interactions with syndecans 
Several different bacteria, parasites and viruses utilize heparan sulfate proteoglycans for 
their initial attachment to the cell membrane but also while entering the cells (Chen et al. 
2008). The wide variety of HSPG binding viruses include herpes simplex virus (Shieh et al. 
1992; WuDunn & Spear 1989), hepatitis E virus (HEV) (Kalia et al. 2009), vaccinia virus 
(Chung et al. 1998), noroviruses (Tamura et al. 2004), AAV (Summerford & Samulski 1998), 
hepatitis C virus (HCV) (Barth et al. 2003) and HIV-1 (Mondor et al. 1998). Although most 
of the viruses bind to the HS moieties, the core protein can also bind ligands (Kirkpatrick et 
al. 2006). Where many different bacteria have been shown to specifically utilize SDC-1 for 
their binding (Chen et al. 2008), only HCV (Shi et al. 2013), HIV-1 (Bobardt et al. 2003) and 
human papilloma virus (Krepstakies et al. 2012) have been so far shown to interact with 
SDC-1. The binding of viruses to HSPGs can be sulfation specific and occur to either N- or 
O-sulfated polysaccharides. Several viruses have been shown to specifically prefer a certain 
sulfation pattern. HCV utilizes N-sulfation (Barth et al. 2003), coxsackievirus N-and 6-O-
sulfation (Zautner et al. 2006) and HEV 6-O-sulfation (Kalia et al. 2009).  
 
2.5 PROTEIN KINASE C 
 
The protein kinase C family consists of serine/threonine kinase enzymes that control the 
function of other proteins by phosphorylating the hydroxyl groups of specific amino acid 
residues. PKCs have an important role in many signaling cascades and they are generally 
activated by diacylglycerol (DAG) or calcium ions (Ca2+). There are over ten known 
isozymes of PKCs in humans (Mellor & Parker 1998; Ohno & Nishizuka 2002) which are 
divided into 3 different subfamilies based on their structural and biological properties 
(Table 6). These are the classical or conventional PKC isotypes (cPKC), the novel isotypes 
(nPKC) and the atypical isotypes (aPKC). All PKCs have highly conserved catalytic 
domains but they differ in their regulatory domains (Mellor & Parker 1998). The classical 
isotypes of PKCs are PKCα, βI, βII and γ. They are activated by phospholipids such as 
phosphatidylserine (PS) in a Ca2+-dependent manner and they also bind DAG (Takai et al. 
1979). Classical PKCs can also be activated with phorbol esters, such as phorbol 12-
myristate 13-acetate (PMA) (Castagna et al. 1982). The use of phorbol esters results in a 
prolonged activation of PKC (Newton 1995). Novel PKCs include PKCδ, ε, η and θ. They 
are not sensitive to Ca2+ but are activated by DAG or phorbol esters in the presence of PS 
(Ono et al. 1988). The last group of PKCs are the atypical kinases which include PKCs ζ and 
ι. These PKCs do not require Ca2+ and they do not respond to PMA or DAG but are 
activated by PS (Ono et al. 1989).  
 
Table 6. Protein kinase C isotypes and their activation. 
Isotype PKCs Activation 
Classical α, βI, βII, γ PS, Ca2+, DAG 
Novel δ, ε, η, θ PS, DAG  
Atypical ζ, ι PS 
 
Protein kinase C members are formed from a single polypeptide which consists of a N-
terminal regulatory region (approx. 20–40 kDa) and a C-terminal catalytic region (approx. 
45 kDa) (Newton 1995) (Figure 8). The C1 domain of the classical and novel PKCs forms the 
DAG/phorbol ester binding site whereas the C2 domain contains the recognition site for PS 
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and in some PKCs, the Ca2+ -binding site. All PKCs also have a pseudosubstrate region in 
the regulatory domain (Steinberg 2008). PKC resides in an inactive conformation due to 
interaction of the regulatory domain with the catalytic domain through pseudosubstrate 
sequences. The binding of cofactors, such as Ca2+ and DAG/phorbol esters to the regulatory 
domain induces a conformational change in the enzyme exposing the substrate-binding site 
and the catalysis then takes place. Activation of PKC is usually associated with membrane 
translocation and prolonged cellular exposure to PKC activators can cause its degradation 
or downregulation. Members of the PKC superfamily play key roles in several cellular 
processes. They are involved in receptor desensitization, modulating membrane structural 
events, regulating transcription, mediating immune responses and in regulating cell growth 
among multiple other functions (Newton 1995). 
 
Figure 8. Different domains of PKCs. Gray represents the pseudosubstrate domain.  
2.5.1 PKCα 
Along with other PKCs, PKCα is also a lipid sensitive enzyme that is activated by growth 
factor receptors that stimulate phospholipase C (PLC). PLC hydrolyzes PIP2 generating 
DAG, which activates PKCand inositol trisphosphate, which further causes mobilization 
of intracellular calcium (Steinberg 2008). PKCα is ubiquitously expressed in all tissues. It is 
involved in multiple cellular functions such as proliferation, apoptosis, differentiation, 
motility and inflammation. When PKCα is activated, it is translocated from the cytosol to 
e.g. the nucleus, focal adhesions and caveolae. The activation of PKCα occurs as a result of 
multiple different kinds of stimuli ranging from receptor activation and cell contact to 
physical stress. The kinase activity of PKCα is regulated by phosphorylation of three 
conserved residues located in its kinase domain: the activation-loop site Thr-497, the 
autophosphorylation site Thr-638 and the C-terminal site Ser-657 (Parker & Bornancin 1997; 
Hansra et al. 1999).  
The integrins are a family of heterodimer forming transmembrane glycoproteins. 18 α- 
and 8 β-integrin genes encode polypeptides that form altogether 24 αβ receptors 
encountered in mammals (Hynes 2002). The extracellular domains of integrins interact with 
multiple ligands such as ECM glycoproteins and cell surface proteins (Humphries et al. 
2006). The cytoplasmic domains of integrins interact with components of the actin 
cytoskeleton. Integrins play a role in tissue structure and cell migration (Bökel & Brown 
2002) and participate in cell adhesion, haemostasis, thrombosis, inflammation, wound 
healing and neoplasia. PKCα has been shown co-localize with β1-integrin and regulate its 
trafficking. The expression of PKCα leads to upregulation of cell surface β1-integrin, 
whereas the stimulation of PKCα leads to β1-integrin internalization (Ng et al. 1999). 
Integrins and syndecans act in co-operation to regulate cytoskeletal dynamics. Thus, PKCα 
has also been linked to interact with SDC-4 and PIP2 binding to the V region of SDC-4 has 
been shown to have a crucial role in the binding and activation of PKC(Oh et al. 1997). 
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Also, the activity of SDC-4 depends on multimerization, which takes place via recruitment 
of PIP2, activation of PKCα, and downstream signaling through the RhoA pathway 
(Sarrazin et al. 2011; Oh 1998; Oh et al. 1997).  
2.5.2 PKCɛ  
PKCε belongs to the novel class of PKCs and is, like the other members of the subfamily, 
sensitive to DAG/phorbol esters and PS. PKCε participates in numerous signaling systems 
and regulates various physiological functions including the activation of nervous, 
endocrine, exocrine, inflammatory and immune systems (Akita 2002). Among all the PKCs, 
PKCε is the only isozyme that has been considered to be oncogenic by contributing to 
malignancy either by enhancing cell proliferation or by inhibiting cell death. PKCε is  
expressed in several tissues and cells, but widely in neuronal, hormonal and immune cells 
(Ono et al. 1988). PKCε requires phosphorylation at three conserved sites to become 
responsive to second messengers: Thr-566 in the activation loop, Ser-729 in C-terminal 
hydrophobic site and Thr-710 at an autophosphorylation site (Takahashi et al. 2000). 
Phosphorylated PKCε is activated by several different second messengers: DAG, 
phosphatidylinositol 3,4,5-triphosphate and fatty acids. The second messenger bound to the 
Cl domain determines the subcellular localization of the kinase. PKCε translocates to the 
plasma membrane and/or cytoskeleton in response to DAG and tridecanoic acids, whereas 
it translocates to Golgi in response to arachidonic and linoleic acids (Shirai et al. 1998). 
PKCɛ has been shown to control the transport of endocytosed β1-integrins to the plasma 
membrane. If the kinase function of the PKCɛ is inhibited, β1-integrin and PKCε become 
reversibly trapped in a tetraspanin (CD81)-positive intracellular compartment (Ivaska et al. 
2002). β1-integrin recycling is controlled by phosphorylation of vimentin by PKCɛ in 
integrin containing intracellular vesicles and the PKCɛ-mediated phosphorylation of 
vimentin regulates the exit from the vesicles to the plasma membrane (Ivaska et al. 2005). 
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3 Aims of the Study 
Insect pathogenic baculoviruses are widely encountered in nature. They have been used in 
recent decades in the production of recombinant proteins but also as gene delivery vehicles 
in mammalian cells. Although some of the events taking place in non-host mammalian cells 
during baculovirus transduction are understood, the exact receptor to which the virus 
binds to and the cellular factors influencing virus transduction are mainly unknown. 
Gaining knowledge of virus transduction starting from the viral interaction with the 
surface of the cells and intracellular events enabling efficient transduction can aid in the 
development of improved viral vectors and in selecting the most suitable target cells for 
baculovirus-mediated gene delivery. 
 
The aim of this study was to investigate: 
 
I) The effect of different cell culture media on baculovirus-mediated transgene 
delivery and the mechanism behind the phenomenon in association with the 
cell cytoskeletal network. 
 
II) The cellular factors leading to efficient baculovirus transduction and the 
factors contributing to the low transduction efficiency in poorly permissive 
cells. 
 
III) The interaction of baculovirus with the cell surface HSPGs and the 
identification of the member(s) participating in the binding and entry of the 
virus into mammalian cells. 
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4 Materials and Methods 
The materials and methods used in the articles I‐III are summarized in the tables shown 
below (Tables 7-12) and are described in more detail in the original publications. 
 
4.1 METHODS 
 
Table 7. Methods used in studies I-III.  
 
Methods Description Used in 
Production of viruses Concentration and production of baculoviruses  I-III 
Analysis of viruses  Titering and immunoblotting  I-III 
In vitro experiments Cell culture 
BV transduction 
BV binding and internalization assays 
Drug treatments 
DNA transfection 
SiRNA transfection 
Receptor clustering 
Sulfation studies 
I-III 
I-III 
II, III 
II, III 
II, III 
II, III 
II, III 
III 
Analytical experiments Flow cytometry analysis 
Immunoblotting 
Cytotoxicity assay (MTT) 
Immunofluoresence labeling 
Quantification of microscopic data 
I-III 
I, III 
II, III 
I-III 
II, III 
 Proteome Profiler Human Phospho-Kinase Array Unpublished data 
 BCA Protein assay kit Unpublished data 
Microscopy Light and fluorescent microscopy 
Confocal microscopy 
I-III 
I-III 
Statistical methods Mean±SEM, unpaired t-test I-III 
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4.2 MATERIALS 
4.2.1 Cell lines 
 
Table 8. Cell lines used in studies I-III.  
 
Cell line Source Descriptions Used in 
293(T) ATCC: CRL-11268 Human embryonic kidney I, III 
HepG2 ATCC: HB-8065 Human hepatocarcinoma cells I-III 
MG-63 ATCC: CRL-1427 Human osteosarcoma cells I, II 
Ea.hy926 University of North Carolina, 
Department of Pathology, NC, USA 
Hybridoma of human lung epithelium 
and human umbilican vein endothelial 
cells  
I-III 
 
RaaSMC (Ylä-Herttuala et al. 1995) Rabbit aortic smooth muscle cells I 
HeLa ATCC: CCL-2 Human cervical cancer cells I 
Sf-9 Invitrogen Spodoptera frugiperda IPLB-Sf-21-AE 
cells 
I-III 
 
4.2.2 Viral vectors 
 
Table 9. Viral vectors used in studies I-III.  
 
Vector name Description Used in 
Ba-CAG-EGFP/WPRE (Mähönen et al. 2007) I-III 
Vp39EGFP (Kukkonen et al. 2003) I 
p24Cherry (Laakkonen et al. 2009) II, III 
LV-GFP VSVG-pseudotyped lentivirus I 
LV-Gp64 Gp64-pseudotyped lentivirus I 
EV1 (Marjomäki et al. 2002) II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
 
4.2.3 Antibodies 
 
Table 10. Antibodies used in studies I-III.  
 
Antibodies Source Used in 
Anti-vimentin Novocastra I 
Anti-α-tubulin Abcam I 
Anti-nuclear lamins A/C 
Anti-vimentin S72 
Anti-vimentin S38 
Anti-vimentin S82 
Anti-beta actin 
Anti-A211E10 (α2-integrin) 
Anti-AcMNPV 
Anti-Arf6 
Novocastra 
Abcam 
Abcam 
Abcam 
Cell Signalling 
From F. Berditchevski  
From L. Volkman 
Thermo Fisher Scientific 
I 
I 
I 
I 
I 
II 
II, III 
III 
Anti-Cd59 
Anti-Cd81 
Anti-EEA-1 
SantaCruz Biotechnology 
SantaCruz Biotechnology 
Transduction Laboratories 
II, III 
II 
II 
Anti-EV1 (Marjomäki et al. 2002) II 
Anti-gp64 From L. Volkman II, III 
Anti-PIP2 Molecular Probes II 
Anti-PKCα Transduction Laboratories II 
Anti-PKCε SantaCruz Biotechnology II 
Anti-pPKCα Upstate Biotechnology II 
Anti-pPKCε Upstate Biotechnology II 
Anti-syndecan-1 SantaCruz Biotechnology II, III 
Anti-syndecan-2 SantaCruz Biotechnology II, III 
Anti-syndecan-3 SantaCruz Biotechnology II, III 
Anti-syndecan-4 SantaCruz Biotechnology II, III 
Anti-vimentin Leica Microsystems II 
Anti-vp39 From L. Volkman II, III 
4.2.4 Constructs and siRNAs 
 
Table 11. Constructs and SiRNAs used in studies I-III.  
 
Construct Description Used in 
Arf6 WT Wild type II 
PH-GFP PIP2 PH-domain binding II 
PKCα DN Dominant negative II 
PKCα WT Wild type II 
PKCε k/m Kinase dead II 
PKCε WT Wild type II 
Sdc-1 WT Wild type I-III 
Syntenin siRNA II 
Vimentin siRNA II 
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4.2.5 Reagents and drugs  
 
Table 12. Reagents and drugs used in studies I-III.  
 
Construct Description Source Used in 
Desulfated heparins 
Phorbol 12-myristate 13-acetate  
2-O, 6-O and N-desulfated heparins 
Activator of PKCs 
Iduron 
Sigma-Aldrich 
III 
II 
PI-PLC Removal of GPI-anchored proteins Sigma-Aldrich II 
Recombinant SDC-1 Competition assay Abcam III 
Sodium chlorate Prevention of CAG sulfation Sigma-Aldrich III 
TRITC-phalloidin Filamentous actin probe Sigma-Aldrich II 
 
4.2.6 Statistical analysis 
 
An unpaired t‐test, performed with PrismTM from GraphPad Software, 
Inc., was used to determine the statistical significance of the data (in Article I, II and III).  
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5 Results and Discussion 
 
The following chapter presents the main results of studies I–III (publications identified by a 
Roman numeral). Unpublished data is also shown. 
 
5.1 BACULOVIRAL INTERACTION WITH HSPGS (II, III) 
 
Baculoviruses have been considered to have a wide tropism in mammalian cells in vitro and 
in vivo. This is thought to be explained by the fact that the virus binds to a general cell 
surface molecule, such as a heparan sulfate proteoglycan or a phospholipid (Duisit et al. 
1999; Tani et al. 2001). However, though some preliminary data exists to support the role of 
HSPGs, no identification of a specific HSPG family member has been previously reported. 
The purpose of the study was to investigate in detail the role of HSPGs in the binding and 
entry of baculoviruses into mammalian cells. Different types of cells were selected, 
permissive 293T and HepG2 cells and poorly permissive MG-63 and Ea.hy926 cells in 
which the intracellular virus trafficking has previously shown to be non-functional 
(Kukkonen et al. 2003).  
5.1.1 Baculovirus interacts and colocalizes with SDC-1 
HSPGs have been suggested to serve as attachment factors for baculoviruses in mammalian 
cells. However, whether any particular HSPGs can serve as a receptor is unknown. So, we 
first studied the two main families, syndecans and glypicans. In order to define if the 
glypican family was involved in the binding, we performed an enzymatic PI-PLC treatment 
for HepG2 and Ea.hy926 cells. The treatment results in the loss of cell surface glypicans. 
The loss was verified by staining the cells with CD59-antibody, which recognizes a member 
of the GPI-anchored protein family. The treatment did not however result in a statistically 
significant decrease in baculovirus binding to the surface of the studied cells (III, Fig. 3) nor 
in the baculovirus transduction (data not shown) thus indicating that the glypican family is 
not involved in the interaction of the baculovirus virion and the cell surface. The results are 
in line and support the previously published data (Laakkonen et al. 2009) and also the fact 
that most of the interactions of pathogens with HSPGs are shown to take place with the 
syndecan family (Chen et al. 2008). 
Since glypicans did not show a role in the interaction, we next assessed the expression of 
syndecans at the surface of HepG2, Ea.hy926, MG-63 and 293T cells. The study was done by 
immunofluorescence staining the surface of the cells with antibodies against the different 
members of the syndecan family. The results were analyzed by confocal microscopy. The 
levels of syndecans-2, -3 and -4 seemed to be more uniform in all cells whereas there was 
more variation detected with syndecan-1 expression (III, Fig. 4). The amount of bound 
baculovirus on the surface of the cells was determined and the binding showed a trend that 
followed SDC-1 expression. This suggested that SDC-1 could be involved in the binding of 
baculovirus onto the cells. Interestingly, baculovirus is known to transduce well cells and 
tissues which have high expression of SDC-1 (Airenne et al. 2013; Su et al. 2004, 
www.proteinatlas.org).  
The involvement of syndecans in the virus-cell interaction was further studied with 
colocalization studies in HepG2 and Ea.hy926 cells. In practice, baculoviral virions were 
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allowed to bind and enter the cells, and baculoviruses and syndecans were then 
immunostained and imaged by confocal microscopy. As a result, no or minimal 
colocalization of baculovirus was detected with syndecan family members 2, 3 and 4. 
However, a clear colocalization was seen with the virus and SDC-1 at several time points 
(III, Fig. 5). This suggests that baculovirus does not only bind to SDC-1 at the cell surface 
but also interacts with it during the entry process. Though the cells examined were of a 
very different phenotype, the common factor was their SDC-1-mediated interaction with 
the baculovirus.  
5.1.2 SDC-1 expression regulates baculovirus transduction efficiency  
In order to further study the role of SDC-1 in baculovirus transduction, we transfected 
HepG2 cells with a SDC-1 encoding plasmid. The transfection resulted in upregulation of 
SDC-1 at the surface of the cells (data not shown). Transduction after transfection led to a 
significantly improved transduction efficiency in flow cytometer analysis (III, Fig. 6D). The 
results thus suggest, that when the expression of cell surface SDC-1 was elevated, the viral 
binding and entry improved which further led to enhanced marker gene expression. 
However, the level of SDC-1 expression is not always directly proportional to the level of  
viral transduction since in some cells expressing SDC-1, e.g. Ea.hy926, viral trafficking can 
be halted (Kukkonen et al. 2003).  
An alternate approach was also used where HepG2 cells were pre-treated with SDC-1 
antibody before baculovirus transduction. The transgene expression was then analyzed 48 
h later with a flow cytometer. The antibody decreased baculovirus transduction efficiency 
compared to the control cells (III, Fig. 6A). Also, a negative effect of the antibody on virus 
entry was observed with confocal microscopy (III, Fig. 6B). This suggests that the receptor 
masking caused by the antibody is able to prevent virus binding which is seen as decreased 
transduction efficiency. A similar type of antibody inhibition approach led to the same 
outcome with HSV-1 in HeLA cells (Bacsa et al. 2010). 
A competition assay with recombinant SDC-1 protein was also carried out. The 
recombinant protein was added in varying concentrations to HepG2 cells before the 
addition of the virus and marker gene expression was analyzed with flow cytometer 48 h 
later. As a result, a dose-dependent inhibition of virus-mediated transgene expression was 
seen (III, Fig. 6C). Although the recombinant SDC-1 protein was not glycosylated it could 
still interfere with transduction. This could be taking place either by SDC-1 directly binding 
to the baculovirus virions and thus competing with the cell surface SDC-1, or by its 
interference with essential intra- and intermolecular syndecan interactions. The latter is 
supported by the fact that for example SDC-1-mediated regulation of αvβ5-integrin activity 
in cell attachment and spreading does not require the HS-GAG chains of SDC-1 (McQuade 
et al. 2006). However, the exact mechanism, and demonstration of direct binding between 
non-glycosylated SDC-1 and baculovirus remains to be verified. 
5.1.3 Baculovirus utilizes specific HSPG sulfation  
HSPGs are highly sulfated molecules and most of their interaction with other molecules 
takes place with the aid of sulfated residues. Our purpose was to study if HSPG sulfation is 
also important in baculovirus binding and transduction. In practice, HepG2 and Ea.hy926 
cells were treated with different concentrations (0-75 mM) of sodium chlorate which leads 
to undersulfated GAGs at the cell surface. As an outcome of the treatment, both binding 
and transduction of baculovirus clearly decreased, consistent with sulfation being 
important in the baculoviral cell interaction (III, Fig. 2A, B). The same treatment has also 
been shown to decrease AAV-2 transduction (Qiu et al. 2000). Since some viruses have been 
shown to bind specifically to sulfated residues, we also wanted to assess if the same applied 
to baculoviruses. For that purpose, we used differentially desulfated heparins; basic 
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heparin, N-desulfated, 2-O-desulfated and 6-O-desulfated heparins, which were incubated 
with viruses before the viruses were added and allowed to transduce 293T and HepG2 
cells. The transduction rate was analyzed 48 h later with a flow cytometer. Pretreatment of 
baculoviruses with both heparin and 2-O-desulfated heparin had an inhibitory effect on the 
transduction rate in both cell lines. However, 6-O-desulfated and N-desulfated heparins 
were not able to influence the baculovirus transduction rate indicating that these sulfations 
are important in the viral interaction with HSPGs (III, Fig. 2C). It can thus be concluded that 
the interaction between baculovirus particles and the cell surface is not solely based on 
random electrostatic interactions, but is indeed specific and requires a specific sulfation 
pattern. N- and 6-O-sulfation of HSPGs have also been seen to be important to coxsackie B 
virus and HIV-1 (Zautner et al. 2006; de Parseval et al. 2005). 
5.1.4 SDC-1 and baculovirus virions form aggregates in poorly permissive cells 
Since it was evident that SDC-1 had a role in baculovirus binding and transduction, we 
further investigated the role of SDC-1 in the poorly permissive context of EA.hy926 and 
MG-63 cells and assessed at which stage the virus was blocked along its internalization 
pathway. For that reason, internalization and differential labeling assays were performed 
and the results were visualized by confocal microscopy. According to the results, the 
majority of the viruses remained on the Ea.hy926 and MG-63 cell surface in large clusters 
even 5 h after virus addition (II, Fig. 2A). The virus was found to be associated with the cell 
surface SDC-1 and not with intracellular SDC-1 (II, Fig. 2B) indicating that the complex had 
not entered the cells. Further studies done in Ea.hy926 cells showed that the colocalization 
of baculovirus particles with SDC-1 stayed constant, whereas colocalization of SDC-1 with 
the baculovirus particles grew over time (II, Fig. 2C), suggesting that baculovirus clusters 
gathered more SDC-1 over time. In permissive HepG2 cells, no large extracellular virus–
SDC-1 clusters were observed (II, Fig. 2B). The results thus indicate that baculovirus 
binding to SDC-1 on poorly permissive cells leads to its aggregation at the cell surface and 
inability to enter the cells. This also explains the poor transduction efficiency. The exact 
reason behind the aggregation remains to be determined. However, it can be due to several 
factors, e.g. the lack or non-functionality of additional molecule(s) involved in efficient 
entry or defective activation of signaling route which prevents the virus/SDC-1 complex 
entering the cells. 
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5.2 CELLULAR FACTORS AFFECTING EFFICIENT BACULOVIRUS 
TRANSDUCTION AND ECHOVIRUS-1 INFECTION (II) 
 
In order to characterize and discriminate cell specific features which affect efficient virus 
transduction, we investigated several cell lines that are known to be permissive and poorly 
permissive to baculoviruses. The human pathogen echovirus-1 (EV-1) was also used in 
these studies. Factors known to affect baculovirus, EV-1 and their receptors were selected 
for investigation. Flow cytometry and confocal microscopy was used to analyze the results.  
5.2.1 The expression levels of viral receptor does not explain the inefficient 
transduction/infection 
To assess if there was a correlation with the expression level of the baculovirus receptor, 
SDC-1, and the EV-1 receptor, α2β1-integrin, for successful viral entry, we immunostained 
the receptors in question in EA.hy926, HepG2 and MG-63 cells and visualized the results 
with the aid of confocal microscopy. All cell lines showed high expression levels of SDC-1 
(II, Fig. 1C) which correlated well with baculovirus binding (II, Fig. 1D). Similar results 
were gained with EV-1 and its receptor α2β1-integrin (II, Fig. 1E, F). Transduction/infection 
assays performed in the same cell lines showed, however, that the level of 
transduction/infection was low in the poorly permissive cells (II, Fig. 1A, B). This 
demonstrates that these cells are deficient for baculovirus transduction and EV-1 infection, 
although they express large amounts of viral receptors at their surfaces and the viruses 
bind efficiently to the cells. In permissive HepG2 cells, both viruses showed high 
transduction and infection levels despite having similar expression levels of the viral 
receptors compared to poorly permissive cells. The data suggests that expression of the cell 
surface receptor does not directly correlate with the efficiency of transduction/infection 
implying that other factors are responsible for the outcome.  
The reason for the inefficient infection of EV-1 in poorly permissive cells was further 
studied by investigating the entry of antibody-clustered α2β1-integrin. It has been 
previously shown that antibody-clustered α2β1-integrin follows the same path as EV1-
clustered α2β1-integrin (Upla et al. 2004; Karjalainen et al. 2008; Karjalainen et al. 2011). No 
block in integrin internalization was detected and clear intracellular clusters were observed 
in all studied cell lines (II, Fig. 2E). Also, no difference was observed between the levels of 
internalized and cell surface integrin in the cells (II, Fig. 2F), leading to the conclusion that 
internalization of α2β1-integrin was not affected in poorly permissive Ea.hy926 and MG-63 
cells. Interestingly, this further suggested that the block in these cells is after the 
internalization step of the EV-1 infection pathway. This implies that there are multiple 
different stages in the cells where the viral trafficking can be halted. 
 
5.2.2 Cellular differences in poorly permissive and permissive cells   
To investigate further the possible factors affecting baculovirus and EV-1 trafficking, we 
studied features that differ between permissive and poorly permissive cell lines by confocal 
microscopy. Proteins were selected under investigation by their association to baculovirus, 
EV-1, SDC-1 or α2β1-integrin trafficking. We first studied the involvement of filamentous 
actin (F-actin) in poorly permissive MG-63 and EA.hy926 cells. According to the results, the 
levels of F-actin in HepG2 cells were high, whereas in poorly permissive cells, the levels 
were clearly lower (II, Fig. 3A). Due to the fact that RhoA has been shown to regulate 
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baculovirus uptake (Laakkonen et al. 2009) and actin dynamics, we also investigated the 
involvement of RhoA in poorly permissive cells. Studies performed with RhoA wt, 
dominant negative and constitutively active (CA) constructs showed that RhoA had no 
apparent effect on baculovirus transduction in Ea.hy926 cells (data not shown), suggesting 
that though F-actin levels were low, changing the actin dynamics with RhoA was not the 
determining factor. However, also other factors could influence actin organization and the 
expression of G-actin can differ between cell lines.  
To further investigate the role of cell cytoskeleton in baculovirus transduction, we 
studied vimentin distribution in HepG2, EA.hy926 and MG-63 cells. According to the 
results, there were considerable differences between these cell lines. The overall levels of 
vimentin were higher in poorly permissive cells compared to the permissive cells. A 
difference was also seen in the form of vimentin within the cells. The poorly permissive 
cells showed a complex vimentin network whereas the permissive cells showed no clear 
network and within those cells, vimentin was seen in vesicle-like structures. This suggested 
that in HepG2 cells vimentin is possibly more in monomeric rather than in the filamentous 
form (II, Fig. 3A). This could thus possibly be one of the crucial factors affecting efficient 
baculovirus transduction and EV-1 infection since infection of some viruses, e.g. African 
swine fever virus (Stefanovic et al. 2005), have been shown to be associated with vimentin 
rearrangement. 
Due to the importance of syntenin in syndecan recycling (Zimmermann et al. 2005) we 
also studied the role of syntenin in more detail in HepG2, EA.hy926 and MG-63 cells. 
According to our data, syntenin expression was high in Ea.hy926 cells whereas in MG-63 
cells, the expression of syntenin was lower but still higher than in HepG2 cells (II, Fig. 3A). 
It could thus be concluded that high syntenin expression levels possibly correlate 
negatively with efficient baculovirus transduction and EV-1 infection. Although EV-1 does 
not require SDC-1 for its infection, syntenin is a multifunctional protein that interacts with 
various other transmembrane and cytoplasmic proteins (Sarkar et al. 2004). 
Both Arf6 and PIP2 are known to regulate syndecan and/or integrin recycling as well as 
actin organization (Macia et al. 2008; Powelka et al. 2004; Zimmermann et al. 2005). Our 
previously shown involvement of Arf6 in the regulation of baculovirus uptake in 
permissive cells (Laakkonen et al. 2009) led us to further investigate the role of Arf6 in 
poorly permissive Ea.hy926 cells. According to the results, the overexpression of Arf6 wild 
type or a CA mutant could not induce baculovirus transduction. No changes were seen in 
PIP2 distribution or dynamics as monitored by a PH-GFP-expressing construct in either of 
the poorly permissive or permissive cells. PH-GFP is a fusion protein which consists of GFP 
and the pleckstrin homology (PH) domain of PLCδ1. The domain is known to bind PIP2 
with high affinity and specificity (Stauffer et al. 1998).  
 Also, no colocalization was observed with baculovirus or EV-1 and Arf6 or PIP2 (data 
not shown). These results thus indicate that though Arf6 and possibly PIP2 have a role in 
baculovirus entry, neither Arf6 nor PIP2 is associated with the inefficient viral 
internalization seen in Ea.hy926 cells. 
PKCα has been shown to be associated with β1-integrin trafficking (Ng et al. 1999), EV-1 
infection (Upla et al. 2004) and SDC-4 interaction (Keum et al. 2004). Hence, both the 
phosphorylated form and the total pool of PKCα were studied in the cells. No significant 
differences were observed between the cell lines in the total pool of PKCα (data not shown), 
whereas the phosphorylated form showed distinctive distribution patterns in the poorly 
permissive cells. In those cells PKCα was mostly seen as cytoplasmic and aggregated in the 
perinuclear compartment. In the permissive HepG2 cells, pPKCα was evenly distributed 
throughout the cell (II, Fig. 3B). As the EV-1 internalization assay was performed, it led to a 
reorganization of the pPKCα pool in HepG2 cells. In Ea.hy926 cells, there was no 
reorganization seen thus implying that though EV-1 is able to internalize, the 
internalization does not lead to efficient infection due to the different pPKCα 
function/response in the cells. Since the activation of PKCα is linked to SDC-4 (Keum et al. 
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2004), our data suggests that SDC-1 might also be involved. In conclusion, we observed 
differences in F-actin, syntenin, vimentin and pPKCα. These changes might further explain 
the difference in baculovirus transduction and EV-1 infection in permissive and poorly 
permissive cell lines. 
 
5.3 CELL CULTURE MEDIUM HAS AN EFFECT ON VIRUS 
TRANSDUCTION/INFECTION (I, II) 
 
It is known that baculovirus transduction is not only dependent on the cell or tissue type, 
but also on the conditions of the transduction. The purpose of our study was to determine if 
different cell culture media had an impact on baculovirus-mediated transgene expression. 
In addition, we wanted to further investigate what could explain the favorable effect that 
was observed with RPMI 1640 medium.  
5.3.1 Baculovirus transduction efficiency is culture medium dependent 
In order to investigate the effect of different cell culture media on baculovirus transduction, 
permissive as well as poorly permissive cells were chosen for the study (HepG2, 293T, 
HeLa, MG-63, RaaSMC and Ea.hy926). Baculoviral particles were used to transduce the 
cells in different media and the data was analyzed with fluorescence microscopy and flow 
cytometry. According to the results, the effect of the cell culture medium was clear in all cell 
lines tested. The amount of EGFP expressing cells was clearly lower in DMEM compared to 
the results gained from RPMI 1640 cultured cells. Even the low gene expression normally 
achieved in DMEM cultured MG-63 and Ea.hy926 cells could be improved when the cells 
were cultured in RPMI 1640 (I, Fig. 1A). A further comparison done between several other 
culture media (F-12, DMEM, MEM, Optimem, RPMI 1640 and McCoys 5A) revealed that 
DMEM was the poorest and RPMI 1640 the best medium in respect to baculovirus 
transduction efficiency (data not shown). The effect of the increased expression was also 
evident with all MOIs used and the increase in the expression from DMEM to RPMI 1640 
was 2.5-fold in HepG2 cells, 9-fold in EA.hy926 cells and 11-fold in MG-63 cells (I, Fig. 1B). 
The results thus suggest that culturing poorly permissive cells in RPMI 1640 leads to 
cellular changes that enable improved baculovirus transduction and enhanced transgene 
expression. The effect of different cell culture media on baculovirus transduction was also 
studied in 293T suspension cells. The results supported the result that RPMI 1640 is one of 
the most optimal media for baculovirus transduction (Lesch et al. 2011). What the exact 
components and mechanisms are behind the phenomenon, needs to be further determined.  
5.3.2 Cell culture medium also affects transduction/infection of other viruses 
To study does the medium affect also transduction efficiency of other viruses, gp64- and 
VSVG-pseudotyped lentiviruses were used to transduce DMEM and RPMI 1640 cultured 
cells. The data was in line with the baculoviral results and both pseudotyped viruses 
showed higher transduction efficiency in RPMI 1640 medium than in DMEM (I, Fig. 2). The 
increase in the expression was 2-fold for gp64-pseudotyped lentiviruses in 293T cells and 
5.8-fold in HeLa cells. VSVG-pseudotyped lentiviruses showed a 1.6-fold increase in the 
expression in 293T cells and 1.8-fold in HeLa cells. The same effect was studied with EV-1. 
RPMI 1640 and DMEM grown Ea.hy926, MG-63 and HepG2 cells were infected with the 
virus (II, Fig. 4A). The infection efficiency doubled in RPMI 1640 medium. This indicates 
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that the medium-effect is not virus specific but rather related to cellular responses to the 
extracellular milieu.  
5.3.3 RPMI 1640 leads to improved nuclear entry of baculoviruses 
Since the effect of RPMI 1640 on baculoviral transduction was clear, the next step was to 
analyze baculoviral nuclear entry and intracellular localization in the transduced Ea.hy926 
and HepG2 cells with the aid of confocal microscopy. Nuclear lamins and the nucleus were 
stained to distinguish the cytoplasm from the nucleus. Differences in the amount of EGFP-
tagged baculoviral nucleocapsids (Kukkonen et al. 2003) located in the nucleus between 
RPMI 1640 and DMEM cultured cells was observed (I, Fig. 4). In the RPMI-cultured cells, 
the nucleocapsids were detected all around the cytoplasm and in the nucleus, whereas in 
DMEM, the nucleocapsids were located mainly outside the nucleus (I, Fig. 4A) suggesting 
that RPMI 1640 medium leads to enhanced nuclear entry of baculoviral nucleocapsids. The 
increased amount of nucleocapsids was also observed in MEM compared to DMEM-
cultured cells (I, Fig. 4B). This suggests that DMEM somehow inhibits virus entry to the 
nucleus and thus causes most of the viruses to remain in the cytosol. 
5.3.4 RPMI 1640 leads to changes in vimentin network  
Cell culture medium has been previously shown to have an effect on the IF network of cells 
(Giese & Traub 1988). For that reason we also studied the effects of RPMI 1640 on the cell 
cytoskeletal network. The experiments were performed by immunostaining IFs (vimentin), 
microtubules and actin filaments of MG-63 and Ea.hy926 cells cultured in DMEM or RPMI 
1640 followed by an analysis with confocal microscopy (I, Fig. 5A–C). Reorganization of the 
vimentin network was observed in RPMI 1640 cultured cells (I, Fig. 5A). The cells showed a 
loose, faint and reorganized vimentin network whereas in DMEM-cultured cells, the 
network was denser. No clear rearrangement of MTs (I, Fig. 5B) or MFs (I, Fig. 5C) was 
detected in any of the cell lines indicating that the main effect of RPMI 1640 on the cell 
cytoskeletal network was through vimentin. 
Vimentin is regulated by phosphorylation and dephosphorylation which leads to an 
exchange between assembled IF polymers and disassembled IF subunits (Eriksson et al. 
2004). We thus studied the presence or absence of phosphate groups on three individual 
serine phosphorylation sites of vimentin (S38, S72 and S82) in MG-63 and Ea.hy926 cells by 
Western blotting (I, Fig. 6). Since phosphorylation of Ser-38 and Ser-72 by cAMP-dependent 
kinase (PKA) has been shown to lead to decelerated assembly kinetics of vimentin subunits 
in vivo, these sites were selected (Eriksson et al. 2004). Ser-38 and Ser-72 have not only been 
shown to be important in determining the assembly state but also in regulating the 
structure of vimentin (Eriksson et al. 2004). The total level of vimentin was high and 
remained fairly constant in both media (I, Fig. 6A). When comparing DMEM vs. RPMI 1640 
cultured cells, there were changes in the phosphorylation patterns of the individual serine 
sites. The phosphorylation of S38 and S72 was changed in RPMI 1640 cultured Ea.hy926 
cells (I, Fig. 6B), whereas in RPMI 1640 cultured MG-63 cells, S82 was altered (I, Fig. 6C). 
This suggests that RPMI 1640 leads to changes in vimentin phosphorylation and thus 
affects its assembly kinetics and structure regulation. The results also suggest, that a more 
phosphorylated and looser vimentin network leads to less of a mechanical barrier for 
viruses and thus enables efficient intracellular viral trafficking. What are the exact events 
and cascades leading to increased vimentin phosphorylation, needs to be further 
determined. 
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5.3.5 RPMI 1640 does not change SDC-1 expression or enhance EV-1 binding 
To determine if the medium change from DMEM to RPMI 1640 affects EV-1 internalization 
or boost the binding of the virus on cells, we measured the binding of EV-1 onto the cells 
grown in either media. There was no difference seen in virus binding (data not shown), 
suggesting that RPMI 1640 medium helps virus trafficking rather than binding to the cells. 
We also wanted to see if the amount of SDC-1 was affected when the cells were grown in 
the different media. RPMI 1640 and DMEM cultured cells were stained with SDC-1 
antibody and analyzed with flow cytometry. There was no significant difference in the 
amount of cell surface SDC-1 (Figure 9) (unpublished data). Altogether this data implies 
that the enhanced transduction/infection of the viruses in RPMI 1640 is not dependent on 
the amount of viral receptors expressed at the cell surface nor the improved virus binding, 
but improved intracellular trafficking. As seen in Ea.hy926 cells, the aggregation of SDC-1 
and baculovirus at the cell surface in DMEM is bypassed when RPMI 1640 is used. The 
factors behind this need to be further determined.   
 
 
 
Figure 9. The effect of cell culture medium on SDC-1 expression. PE stands for the percentage 
of phycoerythrin expressing cells.  
5.3.6 NaHCO3 does not explain the RPMI 1640 effect  
Since it was previously suggested that the amount of NaHCO3 in DMEM can inhibit 
baculovirus transduction (Shen et al. 2007), we further studied the role of NaHCO3 by 
increasing the amount of NaHCO3 in RPMI 1640 to the level found in DMEM, and tested 
the effect on the level of transduction in HepG2, EA.hy926 and MG-63 cells. The addition of 
NaHCO3 into RPMI 1640 resulted in a 2.3-fold decrease in the marker gene expression only 
in Ea.hy926 cells (I, Fig. 3). The effect was mild and statistically insignificant in HepG2 and 
MG-63 cells. The data thus suggests that the decrease in the transduction efficiency seen in 
DMEM is not solely explained by the HCO3− ion concentration or that the RPMI 1640 media 
is able to overcome the negative effect associated with the HCO3− ion.  
5.3.7. RPMI 1640 changes the properties of the cells 
To study the possible factors affecting baculovirus and EV-1 trafficking in different media, 
we studied again the proteins that have previously been associated with baculovirus, EV-1, 
SDC-1 or α2β1-integrin trafficking in context of the medium change to RPMI 1640. Since the 
trafficking of baculovirus (Ohkawa et al. 2010) as well as syndecan (Tkachenko et al. 2004; 
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Fuki et al. 1997) has been shown to be actin dependent, we studied the difference of F-actin 
in poorly permissive MG-63 and EA.hy926 cells and permissive HepG2 cells in the two 
different media. No difference in F-actin was observed (II, Fig. 4B), whereas the expression 
levels of syntenin, a syndecan binding protein important in syndecan recycling 
(Zimmermann et al. 2005), changed in response to the culture medium. In HepG2 cells the 
effect was less clear, whereas in poorly permissive cell lines (II, Fig. 4B), an apparent 
decrease in the syntenin level was detected in RPMI 1640 medium. Further assessment of 
the role of syntenin was performed with a knockdown experiment using a syntenin-
targeted smart pool siRNA. Though the syntenin level was efficiently downregulated (II, 
Fig. 4C) the siRNA treatment had no effect on baculovirus transduction or EV-1 infection, 
implying that syntenin is not a crucial factor in the cell susceptibility to these processes (II, 
Fig. 4D). The results also suggest that since the expression of syntenin itself is not solely 
important, the factors behind the change might be. 
Because PKCα is shown to be important in β1-integrin trafficking (Ng et al. 1999) as well 
as in EV-1 internalization (Upla et al. 2004), the role of pPKCα in the medium phenomenon 
was determined by confocal microscopy. The change of culture medium affected both 
pPKCα distribution and its phosphorylation status within the cells. In RPMI 1640 medium 
cultured MG-63 and EA.hy926 cells, pPKCα was translocated from the cytosol to plasma 
membrane. Also the overall pPKCα expression levels were higher (II, Fig. 4B). The 
induction seen in the phosphorylation levels was also verified with Western blotting (II, 
Fig. 4E). This data together indicates that the enhanced activation of PKCα in RPMI 1640 
could at least partly explain the improved EV-1 infection. Previously, it was shown that the 
use of a phorbol ester led to a similar type of translocation of PKCα from the nucleus to the 
plasma membrane (Li et al. 2002). Since PKCα is activated by Ca2+, DAG and PS, changes in 
the amount of these activators in the cells in response to RPMI 1640 could account for the 
results. What the exact mechanism is, needs to be further determined.  
Further investigation of the role of the vimentin network was also carried out. According 
to our observations, the vimentin network changed in response to the culture medium in 
poorly permissive cell lines. The network was tight and compact in DMEM-cultured cells 
whereas in RPMI-cultured cells, the network was looser. We also observed more 
filamentous vimentin in the cells cultured in DMEM than in RPMI 1640. No changes were 
detected in HepG2 cells (II, Fig. 4B). Since PKCε affects both vimentin dynamics and β1-
integrin trafficking (Ivaska et al. 2005) we wanted to study its possible involvement. No 
changes in the level of total PKCε between the media was detected whereas a clear 
reduction in the phosphorylated form of PKCε in cells cultured in RPMI 1640 was seen (II, 
Fig. 5A). When the pPKCε distribution was monitored after baculovirus internalization, an 
association of pPKCε with baculovirus-syndecan-1 aggregate on the cell surface was 
detected (II, Fig. 5B). However, no association between EV-1 and pPKCε was seen (data not 
shown) suggesting that EV-1 infection does not share the same mechanism as baculovirus 
transduction. A clear downregulation of pPKCε was, however, seen with Western blotting 
in EV-1-treated Ea.hy926 cells in response to EV-1 internalization (II, Fig. 5C) implying that 
changes in the PKCε phosphorylation could regulate EV-1 internalization. When the same 
effect was studied with baculoviruses, no difference in the amount of pPKCε was seen (II, 
Fig. 5C) suggesting that lack of pPKCε downregulation might possibly lead to deficient 
baculovirus internalization.  
It has been previously shown, that inhibition of PKCε can lead to a blockage in α2β1-
integrin recycling and further to its entrapment in CD81-positive vesicles (Ivaska et al. 
2002). Thus the association of CD81 with the baculovirus aggregates was studied. As a 
result, no CD81 was found in the aggregates (data not shown), implying that the CD81 
positive vesicle structures previously reported are not the same seen with baculovirus.  
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5.3.8 PKC activation with PMA leads to different changes in permissive and poorly 
permissive cells 
Both novel and classical PKCs can be activated with phorbol esters, such as PMA. Due to 
the fact that PKCα and PKCε were shown to play a role in the culture medium 
phenomenon, we investigated the effects of PMA treatment on both baculoviral 
transduction as well as EV-1 infection in MG-63, EA.hy926 and HepG2 cells cultured in 
RPMI 1640 and DMEM. The effect of PMA on baculovirus transduction was first monitored 
with the aid of flow cytometer. PMA was able to increase the transduction efficiency in 
HepG2 cells cultured in DMEM, whereas in MG-63 and EA.hy926 cells, the transduction 
efficiency was not significantly changed (II, Fig. 6A). In RPMI 1640 however, the 
transduction efficiency decreased in MG-63 and EA.hy926 cells whereas in HepG2 cells 
there was no significant change. EV-1 infection levels determined by confocal microscopy 
during PMA treatment revealed a similar kind of pattern. In permissive cells, PMA 
increased the infection rate in both media, and in poorly permissive cells, PMA reduced it 
(II, Fig. 6B). The effect of PMA treatment on PKC activation and syntenin expression as well 
as the effects of syntenin knockdown on PKCα activation were also studied with confocal 
microscopy. According to the results, no interdependent regulation was observed (II, Fig. 
6C). The effect of PMA and culture media on the vimentin network were also studied since 
PKCε is activated by PMA. In addition, the medium change to RPMI as well as EV-1 
internalization lead to vimentin downregulation. According to the results, the vimentin 
network was more loosely packed in RPMI-cultured Ea.hy926 cells (II, Fig. 7A). In both 
media, PMA treatment resulted in a more compact vimentin network. However, in HepG2 
cells, neither culture media nor the PMA treatment had any effects on vimentin (II, Fig. 7B), 
suggesting that the changes in vimentin dynamics were possibly responsible for the 
decreased transduction and infection levels seen after PMA treatment in poorly permissive 
cells. As RPMI medium was shown to downregulate pPKCε in the poorly permissive cells, 
these results also imply that PKCε activation by PMA treatment leads to changes in 
vimentin organization in poorly permissive cells. These changes are then able to overcome 
the positive effect of PKCα activation on virus internalization, resulting thus in reduction in 
baculovirus transduction and EV-1 infection.  
In addition to filamentous versus monomeric forms of vimentin observed in the poorly 
permissive and permissive cells, poorly permissive cells also expressed higher levels of 
vimentin than the permissive cells. In order to see if a reduction of vimentin levels had any 
effect on baculovirus transduction and EV-1 infection, we used a vimentin targeted smart 
pool siRNA approach and monitored the transduction and infection levels with confocal 
microscopy. Vimentin knockdown did not have an obvious effect on EV-1 infection or 
baculovirus transduction in poorly permissive cells (II, Fig. 7C). This suggests that instead 
of the overall vimentin level, the organization of vimentin is more crucial in the virus 
transduction and infection. To confirm that vimentin overexpression was not the restricting 
factor in PMA-treated cells, vimentin siRNA treatment was performed along with PMA 
treatment (II, Fig. 7B). The success of vimentin knockdown with the siRNA treatment was 
verified by confocal microscopy. Although the treatment did not reduce vimentin 
expression to zero (77% knockdown), it was able to significantly diminish vimentin 
expression (II, Fig. 7D). However, vimentin overexpression was not the restricting factor in 
PMA-treated cells. The results thus suggest that the unfavorable effects of the vimentin 
network on cellular entry and intracellular trafficking of viruses is not due to the vimentin 
levels, but rather changes in the PKCε regulated vimentin organization. What factors are 
leading to the changes in the PKCε regulation needs to be further studied. In conclusion, 
the key factors affecting baculovirus transduction and EV-1 infection in different cell 
culture media are PKC subtypes α and ε together with vimentin reorganization. 
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5.4 CELL SIGNALLING DURING BACULOVIRUS TRANSDUCTION 
(unpublished data) 
The aim of this study was to investigate the intracellular differences in kinase 
phosphorylation between poorly permissive (EA.hy926; DMEM and RPMI 1640) and 
permissive (HepG2; MEM) cells cultured in different media after baculovirus transduction. 
No previous data of protein kinase activities in mammalian cells during baculovirus 
transduction exists. The commercially available antibody based Proteome Profiler Human 
Phospho-Kinase Array (R&D Systems) was used to measure phosphorylation differences in 
protein content normalized samples. A multiplicity of infection of 1000 and time points of 
0.5 h and 4 h post transduction (pt) were selected since the majority of the virus should be 
at those time points in the entry pathway, early endosomes or in the nucleus (Salminen et 
al. 2005; Matilainen et al. 2005). The signal from the phosphorylated kinases was developed 
by Super signal West Dura Extended Substrate and the intensities of the detected signals 
were measured by Nonlinear Dynamics Totallab TL120 software. The presented results are 
replicates of two independent experiments. 
5.4.1 Different kinases and pathways are active during baculovirus transduction in 
different media  
Phosphokinase activation was studied in MEM cultured HepG2 cells and DMEM/RPMI 
1640 cultured EA.hy926 cells. In EA.hy926 cells cultured in DMEM, no significant increase 
or decrease of phosphorylation was observed in most of the kinases within the two 
different time points when compared to the untransduced cells (Figure 10). Only two 
kinases, paxillin and FAK were detected to be significantly upregulated at 4 h pt compared 
to 0.5 h pt (Table 13, *p<0.05). The results thus indicate, that as previously seen in DMEM-
cultured EA.hy926 cells, the viruses remain mainly at the cell surface (II) or in the cytosol 
(I). The lack of a kinase response also possibly explains the halted virus trafficking seen in 
EA.hy926 cells. In HepG2 cells, several kinases showed increased phosphorylation states 
during baculovirus transduction compared to mock treated cells (Figure 11). It was also 
observed that as the transduction proceeded, activation of kinases increased. In HepG2 
cells, which are one of the most permissive cells for baculovirus, the virus transduction thus 
clearly leads to intracellular changes through the activation of kinases which probably 
accounts for the efficient virus delivery to the nucleus.  
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Figure 10. Phosphorylation state of different kinases in DMEM cultured and baculovirus 
transduced EA.hy926 cells.  
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Figure 11. Phosphorylation state of different kinases in MEM cultured and baculovirus 
transduced HepG2 cells.  
41 
 
 
Since the use of RPMI 1640 medium during baculoviral transduction clearly leads to 
enhanced nuclear transport of viral nucleocapsids in poorly permissive cells (I), it was 
reasonable to expect some changes also in kinase activity. When we compared the different 
time points after baculovirus transduction (0.5 h and 4 h) in RPMI 1640 grown EA.hy926 
cells (Figure 12), we saw an increase in the phosphorylation of 27 kinases (Table 13) 
compared to non-treated cells. Among these kinases, increased phosphorylation of 21 
kinases was statistically significant indicating that RPMI 1640 medium affects the activation 
of kinases.  
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Figure 12. Phosphorylation state of different kinases in RPMI 1640 cultured and baculovirus 
transduced EA.hy926 cells.  
The kinase phosphorylation pattern seen in RPMI 1640 cultured EA.hy926 after 
baculovirus transduction resembled the one in MEM-cultured highly permissive HepG2 
cells (Table 13) indicating that the cell response to RPMI 1640 culture medium was 
favorable for baculovirus entry. 
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Table 13. Comparison of kinase responses between control and baculovirus transduced cells. 
Yes indicates upregulated phosphorylation compared to control cells. Ns indicates statistical 
non-significance and * means statistical significance (at least *p<0.05). 
 
Kinase Phosphorylation site 
HepG2 
MEM 
EA.hy926 
RPMI 
EA.hy 926 
DMEM  
 
P38a 
ERK1/2 
JNKpan 
GSK-3a/b 
MEK1/2 
MSK1/2 
Akt 
Akt(T305) 
p53(S46) 
TOR 
CREB 
HSP27 
AMPKa2 
b-catenin 
p53 
p27 
Paxillin 
Src 
Lyn 
Lck 
P70S6 Kinase 
RSK1/2/3 
p27 
PLC gamma-1 
Fyn 
Yes 
p70S6 Kinase 
RSK1/2 
c-Jun 
Pyk2 
Hck  
Chk-2 
FAK 
eNOS 
T180/Y182 
T202/Y204, T185/Y187 
T183/Y185, T221/Y223 
S21/S9 
S218/S222, S222/S226 
S376/S360 
S473 
T308 
S46 
S2448 
S133 
S78/S82 
T172 
 
S15 
T198 
Y118 
Y419 
Y397 
Y394 
T421/S424 
S380/S386/S377 
T157 
Y783 
Y420 
Y426 
T229 
S221/S227 
S63 
Y402 
Y411 
T68 
Y397 
S1177 
Yes 
Yes 
Yes 
Yes 
Yes* 
Yes* 
Yes 
Yes 
- 
Yes* 
Yes 
Yes* 
Yes 
Yes 
- 
Yes 
Yes* 
Yes* 
Yes(ns) 
Yes(ns) 
Yes 
Yes 
Yes 
Yes* 
Yes* 
Yes* 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes* 
Yes* 
Yes 
- 
- 
Yes (ns) 
- 
Yes* 
Yes* 
- 
Yes* 
- 
Yes* 
Yes* 
Yes* 
Yes (ns) 
Yes (ns) 
Yes* 
Yes* 
Yes (ns) 
Yes* 
Yes* 
Yes* 
Yes* 
Yes* 
Yes* 
Yes* 
Yes* 
Yes* 
Yes (ns) 
Yes* 
- 
Yes* 
Yes (ns) 
Yes* 
Yes* 
- 
Yes (ns) 
- 
Yes 
- 
- 
- 
- 
Yes 
- 
- 
- 
- 
- 
- 
- 
- 
Yes* 
- 
- 
Yes 
- 
- 
- 
Yes 
- 
- 
- 
- 
- 
Yes 
- 
Yes 
Yes* 
Yes 
 
      
 
In order to find out the kinase signaling cascades involved in baculovirus transduction, 
we fitted the different activated kinases into two available signaling pathway databases 
(http://www.genome.jp and http://www.cellsignal.com). Four signaling pathways; the 
MAPK signaling pathway, the mTOR signaling pathway, the integrin signaling pathway 
and the PI3K signaling pathway (Figure 13) were activated during baculovirus 
transduction. We then further investigated pathways in which the key kinases were shared 
by both cell types. Accordingly, the MAPK signaling pathway was ruled out since the cells 
did not share some of the key kinases involved in the cascade (Figure 13), e.g. there was a 
significant increase in the phosphorylation of MEK1/2 in Ea.hy926 cells, whereas in ERK1/2 
there was not, although it is a key downstream effector of MEK1/2. As a result, it could be 
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concluded that the integrin (Fyn, Akt, FAK and Src), PI3K (Akt, Fyn, PLC) and mTOR 
(mTOR, RSK1/2, p70S6K) pathways might have a role in baculovirus entry into mammalian 
cells. 
 
 
 
Figure 13. Involvement of different possible signaling pathways in baculovirus transduction. 
Black circles represent HepG2 cells and blue RPMI-1640 cultured EA.hy926 cells. Classification 
of kinases is based on the KEGG pathway database (http://www.genome.jp) and (Pelkmans et 
al. 2005). 
 
However, the presented preliminary results are not conclusive since many of the kinases 
have differential roles in several pathways. The study covers thus far 34 different kinases 
and gives a partial clue about the possible pathways involved. Altogether, the data 
presented here demonstrates that baculoviruses utilize 6-O and N-sulfated syndecan-1 for 
its binding and entry. The use of optimized cell culture medium leads to improved 
transduction efficiency and intracellular changes in the cells. These changes include the 
activation of PKCα, deactivation of PKCε and a looser vimentin network (Figure 14). In 
conclusion, the data presented in this study can give important insights about the factors 
affecting baculovirus transduction and may be used in the future to develop improved viral 
vectors for gene transfer purposes.  
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Figure 14. Factors affecting efficient baculovirus transduction. Baculoviral particles bind and 
enter into cells with N- and 6-O-sulfated syndecan-1. Also additional receptors might be 
involved. Factors that affect efficient baculovirus transduction within the cells include the 
activation of PKCα, deactivation of PKCε and a looser vimentin network. Signaling cascades that 
seem to be involved in the transduction process include the integrin, PI3K and mTor cascades.  
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6 Summary and Conclusion 
 
The main conclusions of the thesis are: 
 
I Cell culture medium has an effect on baculovirus‐mediated gene delivery. The use of an 
optimized medium leads to enhanced nuclear entry of baculoviruses and efficient 
transgene expression. Changes associated with the culture medium are seen in the vimentin 
network.  
 
II Virally poorly permissive cells show differential expression of F-actin, vimentin, PKCα 
and PKCε compared to permissive cells. A medium change to RPMI 1640 leads to lower 
expression levels of syntenin and differential regulation of PKCα and ε along with a looser 
vimentin network.  
 
III AcMNPV utilizes HSPGs in binding and entry into mammalian cells. The virus does not 
bind to glypicans but requires 6-O- and N-sulfated syndecan-1. In poorly permissive cells, 
the virus and its receptor form aggregates which remain at the surface of the cells being 
unable to internalize. 
 
IV Differential kinase activation patterns are seen in poorly permissive and permissive cells 
which can partly explain the differences seen in the transduction efficiencies between the 
cells. However, the use of an optimized cell culture medium is able to change the kinase 
phosphorylation pattern of poorly permissive cells towards that of permissive cells.  
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Baculoviruses are insect specific 
viruses which can also transfer 
genes into mammalian cells. In 
this thesis, the receptor that the 
virus uses to bind to mammalian 
cells was discovered. Also, factors 
that influence the outcome of 
baculovirus transduction were 
identified. The results reveal 
important insights about cellular 
factors affecting baculovirus 
transduction and may be used in 
the future to develop improved 
viral vectors for gene transfer 
purposes.
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